Ïðèìå÷àíèÿ êíèãè: Ìîëîäîñòü íàâñåãäà. Êàê çàìåäëèòü ïðîöåññû ñòàðåíèÿ è ñîõðàíèòü çäîðîâüå - ÷èòàòü îíëàéí, áåñïëàòíî. Àâòîð: Äóíêàí Êàðìàéêë

÷èòàòü êíèãè îíëàéí áåñïëàòíî
 
 

Îíëàéí êíèãà - Ìîëîäîñòü íàâñåãäà. Êàê çàìåäëèòü ïðîöåññû ñòàðåíèÿ è ñîõðàíèòü çäîðîâüå

Âñå ìû áîèìñÿ ñòàðåíèÿ è òîãî, êàê îíî ìîæåò ïîâëèÿòü íà íàøå òåëî è ðàçóì. Íî ÷òî, åñëè ìû ìîæåì ïðÿìî ñåé÷àñ íà÷àòü ÷òî-òî ìåíÿòü â ñâîåé æèçíè, ÷òîáû çàìåäëèòü ñòàðåíèå, ïðîäëèòü ìîëîäîñòü, óëó÷øèòü ñâîå çäîðîâüå íà äîëãèå ãîäû, ñîõðàíèòü àêòèâíîñòü è ñ÷àñòüå? Õîðîøàÿ íîâîñòü: î÷åíü ìíîãîå â íàøèõ ðóêàõ, è ãåíû – íå ïðèãîâîð, âåäü îò ãåíåòèêè â ýòîé ñôåðå çàâèñèò ãîðàçäî ìåíüøå, ÷åì îò îáðàçà æèçíè. Äîêòîð Äóíêàí Êàðìàéêë, àâòîðèòåòíûé ñïåöèàëèñò ïî àíòèâîçðàñòíîé ìåäèöèíå, îáîáùèë â ýòîé êíèãå ñâîé 25-ëåòíèé îïûò êëèíè÷åñêîé ðàáîòû, ïðåïîäàâàíèÿ è èññëåäîâàíèé, èçëîæèâ îãðîìíîå êîëè÷åñòâî èíôîðìàöèè â äîñòóïíîé, óäîáî÷èòàåìîé ôîðìå. Çäåñü ðàññìàòðèâàþòñÿ òàêèå òåìû, êàê ïèòàíèå, äèåòû, òîêñèíû, âîçäåéñòâèå ñòðåññà, ãîðìîíû, ìóæñêîå è æåíñêîå çäîðîâüå, à òàêæå – ïî÷åìó íàøà êîæà, ìîçã è ïå÷åíü ñòàðåþò, êàê èñïðàâèòü óæå èìåþùèéñÿ óùåðá è ïðåäîòâðàòèòü ïîñëåäóþùèå âîçðàñòíûå èçìåíåíèÿ. «Ñîâðåìåííûé ìèð äàåò âîçìîæíîñòü êàê ïîääåðæèâàòü çäîðîâüå â ïðå-êðàñíîì ñîñòîÿíèè, òàê è åùå â ìîëîäîì âîçðàñòå „çàðàáîòàòü“ òÿæåëûå õðîíè÷åñêèå çàáîëåâàíèÿ. Î÷åâèäíî, ÷òî â áîëüøèíñòâå ñëó÷àåâ íàøå çäîðîâüå â íàøèõ ðóêàõ. Âîïðîñ â òîì, êàê îïðåäåëèòü, ÷òî ïîìîãàåò, à ÷òî âðåäèò? Âñå òàê áûñòðî ìåíÿåòñÿ âî âñåõ îáëàñòÿõ ìåäèöèíû, ÷òî â÷åðàøíåå ëåêàðñòâî çàâòðà ìîæåò áûòü ïðèçíàíî âðåäíûì (è ýòî íå ó÷èòûâàÿ àôåðèñòîâ â áåëûõ õàëàòàõ, ïûòàþùèõñÿ âïàðèòü øàðëàòàíñêèå ñðåäñòâà îò âñåõ áîëåçíåé). Ïîèñê íàäåæíîé èíôîðìàöèè â ýïîõó èíòåðíåòà ñòàíîâèòñÿ íåëåãêîé çàäà÷åé. Ìîÿ öåëü – ñîñòàâèòü äëÿ âàñ ïîëåçíóþ äîðîæíóþ êàðòó». (Äóíêàí Êàðìàéêë)

Ïåðåéòè ê ÷òåíèþ êíèãè ×èòàòü êíèãó « Ìîëîäîñòü íàâñåãäà. Êàê çàìåäëèòü ïðîöåññû ñòàðåíèÿ è ñîõðàíèòü çäîðîâüå »

Ïðèìå÷àíèÿ

1

Ïåð. ñ ëàò. Ò. Þ. Áîðîäàé. – Ïðèì. ïåð.

2

Ridker, P. M. et al. ‘C-Reactive Protein Adds to the Predictive Value of Total and HDL Cholesterol in Determining Risk of First Myocardial Infarction.’ Circulation (1998): 97: 20: 2007–2011.

3

Hooper, L. et al. ‘Reduced or Modified Dietary Fat for Preventing Cardiovascular Disease.’ The Cochrane Library (2012).

4

Lustig, R. Fat Chance: The Hidden Truth About Sugar, Penguin (2014).

5

US Department of Health and Human Services and US Department of Agriculture. ‘2015–2020 Dietary Guidelines for Americans.’ 8th Ed. (December 2015). Ïîëíûé òåêñò îïóáëèêîâàí îíëàéí: http://health.gov/dietaryguidelines/2015/guidelines/.

6

Ibid.

7

Olshansky, S. J. et al. ‘A Potential Decline in Life Expectancy in the United States in the 21st Century.’ N Engl J Med (2005): 352: 1138.

8

Gardner, M. ‘The Doctor’s Choice is America’s Choice.’ Am J Public Health (2006): 96: 222–232.

9

Ñì., íàïðèìåð: ‘The NHS in Numbers: Then and Now.’ BBC (2008). http://news.bbc.co.uk/2/hi/health/7475035.stm.

10

Ñì., íàïðèìåð: ‘Former Advertising Executive Reveals Junk Food-pushing Tactics’ by Sarah Boseley, The Guardian (2 January 2018).

11

Brown-Borg, H. M. ‘Hormonal Regulation of Longevity in Mammals.’ Ageing Res Rev (2007): 6: 28–45.

12

Li, J. et al. ‘Intravenous Magnesium for Acute Myocardial Infarction.’ Cochrane (2007). http://www.cochrane.org/CD002755/VASC_intravenous-magnesium-for-acute-myocardial-infarction/.

13

Daoud, J. et al. ‘Pancreatic Islet Culture and Preservation Strategies: Advances, Challenges and Future Outlooks.’ Cell Transplant (2010): 19 (12): 1523–1535.

14

Cave, S. Immortality: The Quest to Live Forever and How It Drives Civilization. Crown (2012).

15

The Global Religious Landscape. Pew Research Center. 2012: http://www.pewforum.org/2012/12/18/global-religious-landscape-exec/.

16

Ïåðåâîä Â. Ìàðêîâà (Äæåáðàí Õ. Ñòðàííèê. Ïðèò÷è è ðå÷åíèÿ. Ì.: Ñôåðà, 2002). – Ïðèì. ïåð.

17

Ïåðåâîä Ò. Þ. Áîðîäàé (Ëóöèé Àííåé Ñåíåêà. Ôèëîñîôñêèå òðàêòàòû. ÑÏá.: Àëåòåéÿ, 2001). – Ïðèì. ïåð.

18

‘We will be able to live to 1,000.’ BBC News (2004). URL: http://news.bbc.co.uk/2/hi/uk/4003063.stm.

19

Bekaert, S. et al. ‘Telomere biology in mammalian germ cells and during development.’ Develop Biol (2004): 274: 15–30.

20

Campisi, J. ‘Aging, cellular senescence and cancer.’ Annu Rev Physiol (2013): 75: 685–705. URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4166529/

21

Ozturk, S. ‘Telomerase activity and telomere length in male germ cells.’ Biol Reprod (2015): 92: 53.

22

Latorre, E. et al. ‘Small molecule modulation of splicing factor expression is associated with rescue from cellular senescence.’ BMC Cell Biol (2017): 18: 31. URL: https://bmccellbiol.biomedcentral.com/articles/10.1186/s12860-017-0147-7

23

Áàçàëüíàÿ òåìïåðàòóðà òåëà – ñàìàÿ íèçêàÿ òåìïåðàòóðà, äîñòèãàåìàÿ òåëîì âî âðåìÿ îòäûõà (îáû÷íî âî âðåìÿ ñíà). – Ïðèì. íàó÷. ðåä.

24

Arias, E. et al. ‘United States life tables eliminating certain causes of death 1999–2001.’ National Vital Statistics Reports (2013): 61: 9. URL: https://www.cdc.gov/nchs/data/nvsr/nvsr61/nvsr61_09.pdf.

25

Ibid.

26

Herskind, A. M. et al. ‘The heritability of human longevity: a population-based study of 2872 Danish twins born 1870–1900.’ Human Genetics (1996): 97: 319–323.

27

Baker, D. J. et al. ‘Naturally occurring p16ink4a positive cells shorten healthy lifespan.’ Nature (2016): 530–184–89. URL: https://www.nature.com/articles/nature16932.

28

‘A billion shades of grey’. The Economist (26 April 2014).

29

Masternak, M. M. et al. ‘Growth hormone, inflammation and aging.’ Pathobiol Aging Age Relat Dis(2012): 2: 10. URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3417471/.

30

Carmona-Gutierrez, C. et al. ‘The crucial impact of lysosomes in aging and longevity.’ Ageing Res Rev (2016): 32: 2–12.

31

Bartke, J. ‘Growth hormone and aging: A challenging controversy.’ Clin Interv Aging (2008): 3: 659–665.

32

Zhang, X. et al. ‘Fasting insulin, insulin resistance and risk of cardiovascular or all-cause mortality in non-diabetic adults: A meta-analysis.’ Biosci Rep (2017): 37. URL: https://www.ncbi.nlm.nih.gov/pubmed/28811358.

33

Ravaglia, G. et al. ‘Determinants of Functional Status in Healthy Italian Nonagenarians and Centenarians: A Comprehensive Functional Assessment by the Instruments of Geriatric Practice.’ J Am Geriatr Soc (1997): 45: 10: 1196–1202.

34

Sarrel, P. M. et al. ‘The mortality toll of oestrogen avoidance: An analysis of excessive deaths among hysterectomized women aged 50 to 59 years.’ Am J Public Health (2013): 103: 1583–1588.

35

Hanke, H. et al. ‘Effect of testosterone on plaque development and androgen receptor expression in the arterial vessel wall.’ Circulation (2001): 103: 1382–1385.

36

Fukai, T. et al. ‘Superoxide dismutases: Role in redox signaling, vascular functioning and diseases. Antioxid Redox Signal (2011): 15: 1583–1606.

37

Morgan, M. J. et al. ‘Crosstalk of reactive oxygen species and NFkB signaling.’ Cell Res (2011): 21: 103–115.

38

Reiter, R. J. et al. ‘Melatonin as an anti-oxidant: Under-promises but over-delivers.’ J Pineal Res (2016): 61: 253–278.

39

Dreher, F. ‘Topical antioxidants protect against UVA & UVB sun damage.’ Curr Probl Dermatol (2001): 29: 157–164.

40

Stadtman, E. R. ‘Review: Protein oxidation and aging.’ Science (1992): 257: 1220–1224.

41

Van Raamsdonk, J. et al. ‘Deletion of the mitochondrial Superoxide dismutase SOD-2 extends life in Caenorhabditis Elegans.’ PLoS Genetics (2009). URL: http://journals.plos.org/plosgenetics/article?id=10.1371/journal.pgen.1000361

42

Sun, J. et al. ‘Sequential Upregulation of Superoxide Dismutase 2 and Heme Oxygenase 1 by tert-Butylhydroquinone Protects Mitochondria during Oxidative Stress.’ Mol Pharmacol (2015): 88 (3): 437–449.

43

Davies, K. J. et al. ‘Free radicals and tissue damage produced by exercise.’ Biochem Biophys Res Commun (1982): 107: 1198–1205.

44

Hitomi, Y. et al. ‘Acute exercise increases expression of extracellular superoxide dismutase in skeletal muscle and the aorta.’ Redox Rep (2008): 13 (5): 213–216.

45

Morgan, M. J. et al. ‘Crosstalk of reactive oxygen species and NFκB signalling.’ Cell Res (2011): 21: 103–315.

46

Harman, D. ‘Free radical theory of aging: dietary implications.’ Am J Clin Nutr (1972): 839–843.

47

Andziak, B. et al. ‘Antioxidants do not explain the disparate longevity between mice and the longest living rodent, the naked mole-rat.’ Mech Ageing Dev (2005): 126: 1206–1212.

48

Ozawa, T. ‘Mitochondrial DNA Mutations and Age.’ in Towards Prolongation of the Healthy Lifespan: Practical Approaches to Intervention. Eds D. Harman, R. Holliday. New York Academy of Sciences (1998).

49

Stadtman, E. R. ‘Protein oxidation and aging.’ Science 257 (1991): 1220–1224.

50

Zuo, Y. et al. ‘Black rice extract extends the lifespan of fruit flies.’ Food Funct (2012). http://pubs.rsc.org/-/content/articlelanding/2012/fo/c2fo30135k/unauth#!divAbstract.

51

Dreher, F. ‘Topical antioxidants protect against UVA & UVB sun damage’. Curr Probl Dermatol (2001): 29: 157–164.

52

Andziak, B. et al. ‘Antioxidants do not explain the disparate longevity between mice and the longest living rodent, the naked mole-rat’. Mech Ageing Dev(2005): 126: 1206–1212.

53

Guallar, E. et al. ‘An editorial update: Annus horribilis for vitamin E.’ Ann Intern Med (2005): 143: 143–145.

54

Melov, S. et al. ‘Extension of life-span with superoxide dismutase/catalase mimetics.’ Science (2000): 289: 1567–1569.

55

Bayne, A. C. et al. ‘Effects of superoxide dismutase/catalase on lifespan and oxidative stress resistance in the housefly, Musca domestica.’ Free Radic Biol Med (2002): 32: 1229–1234.

56

Rose, M. R. The Long Tomorrow: How Advances in Evolutionary Biology Can Help Us Postpone Aging. Oxford University Press, USA (2005).

57

Kenyon, C. et al. ‘A C elegans mutant that lives twice as long as wild type.’ Nature 366: 1993: 404–405.

58

Martins, R. et al. ‘Long live FOXO: unravelling the role of FOXO proteins in aging and longevity.’ Aging Cell (2016): 15: 196–207.

59

Sinclair, D. A. et al. ‘Small molecule activators of sirtuins extend Saccharomyces cere-visiae lifespan.’ Nature (2003): 425: 191–196.

60

Sinclair, D. et al. ‘Sirtuin activators mimic caloric restriction and delay ageing in meta-zoans.’ Nature (2004): 430: 686–689.

61

Khushwant, S. ‘Lifespan and healthspan extension by resveratrol.’ BBA Mol Basis Dis (2015): 1852: 1209–1218.

62

Semba, R. D. et al. ‘Resveratrol levels and all-cause mortality in older community-dwelling adults.’ JAMA (2014): 174: 1077–1084.

63

Nedergaard, M. et al. ‘Beneficial effects of low alcohol exposure, but adverse effects of high alcohol intake on glymphatic function.’ Nature Res (2018): 8: 2246. URL: https://www.nature.com/articles/s41598–018–20424y.

64

Park, D. et al. ‘Resveratrol induces autophagy by directly inhibiting mTOR through ATP competition.’ Nature (2016): 6: 21772. URL: https://www.nature.com/articles/srep21772.

65

‘Cynthia Kenyon: “The idea that ageing was subject to control was completely unex-pected.” ’ The Guardian (2013).

66

Ehninger, D. et al. ‘Longevity, aging and rapamycin.’ Cell Mol Life Sci (2014): 71: 4325–4346.

67

Hammel, H. T. et al. ‘Thermal and metabolic responses of the Kalahari bushmen to moderate cold at night.’ Researchgate (1963). URL: https://www.researchgate.net/publication/235016637_Thermal_and_metabolic_responses_of_the_Kalahari_bushmen_to_moderate_cold_exposure_at_night.

68

Keil, G. et al. ‘Being cool. How body temperature influences ageing and longevity.’ Biogerontology (2015): 16: 383–397.

69

Simonsick, E. M. et al. ‘Basal body temperature as a biomarker of healthy aging.’ Age (2016): 38: 445–454.

70

Mooventhan, A. et al. ‘Scientific evidence-based effects of hydrotherapy on various systems of the body.’ N Am Med J Sci (2014): 6: 199–209.

71

Peake, J. M. et al. ‘The effects of cold water emersion and active recovery on inflammation and cell stress responses in human skeletal muscle after resistance exercise’. J Physiol (2017): 595: 695–711.

72

Semenza, J. C. et al. ‘Heat-related deaths during the July 1995 heat wave in Chicago.’ N Engl J Med (1996): 335: 84–90.

73

McCay, C. M. et al. ‘The effect of retarded growth upon the length of life span and upon the ultimate body size’ (1935). Nutrition (1989): 5: 155–171.

74

Lee, C. et al. ‘Dietary restriction with and without calorie restriction for healthy aging.’ MC (2016): 5. URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC 4755412/.

75

Speakman, J. R. et al. ‘Starving for life: What animal studies can and cannot tell us about the use of Caloric Restriction to prolong human Lifespan.’ J Nutr 137: (2007): 1078–1086.

76

Gredilla, R. et al. ‘Caloric restriction decreases mitochondrial free radical generation at complex 1 and lowers oxidative damage to mitochondrial DNA in the rat heart.’ FASEB Journal (2001). URL: http://www.fasebj.org/doi/10.1096/fj.00–0764fje.

77

Lin, S. J. et al. ‘Calorie restriction extends Saccharomyces by cerevisiae lifespan by increasing respiration.’ Nature (2002): 418: 344–348.

78

Greer, E. L. et al. ‘Dif erent dietary restriction regimens extend lifespan by both independent and overlapping genetic pathways in C. elegans.’ Aging Cell (2009): 8: 113–127.

79

Soare, A. et al. ‘Long-term calorie restriction, but not endurance exercise lowers core body temperature in humans.’ Aging (2011): 374–379.

80

Larson-Meyer, D. E. et al. ‘Effect of calorie restriction with or without exercise on insulin sensitivity, B-cell function, fat cell size and ectopic lipid in overweight subjects.’ Diabetes Care (2006): 29: 1337–1344.

81

Longo, V. D. et al. ‘Evolutionary medicine: from dwarf model systems to healthy centenarians?’ Science (2003): 299: 1343–1346.

82

Guarente, L. and Kenyon, C. ‘Genetic pathways that regulate ageing in model organisms.’ Nature (2000): 408: 255–262.

83

Roberts, M. N. et al. ‘A ketogenic diet extends longevity and healthspan in adult mice.’ Cell Metabolism (2017): 26: 539–546.

84

Johnston, B. C. et al. ‘Comparison of Weight Loss Among Named Diet Programs in Overweight and Obese Adults: A Meta-analysis.’ JAMA (2014): 312: 923–933.

85

Chan, Y. C. et al. ‘Calorie restriction in the Okinawa people of Japan.’ J Cell Nutr (1997).

86

Anson, R. M. et al. ‘Intermittent fasting dissociates beneficial effects of dietary restriction on glucose metabolism and neuronal resistance to injury from calorie intake.’ Proc Natl Acad Sci USA (2003): 100: 6216–6220.

87

Ïåðèîäè÷åñêîå ãîëîäàíèå íå ðåêîìåíäóåòñÿ ëþäÿì, ó êîòîðûõ äèàãíîñòèðîâàí áèëèàðíûé ñëàäæ èëè êàìíè â æåë÷íîì ïóçûðå. Êàòåãîðè÷åñêè íåëüçÿ ãîëîäàòü ëþäÿì ñ èíñóëèíîçàâèñèìûì äèàáåòîì è ïàöèåíòàì ñ èíñóëèííåçàâèñèìûì äèàáåòîì, ïðèíèìàþùèì ëåêàðñòâà äëÿ ñíèæåíèÿ ñàõàðà êðîâè. – Ïðèì. íàó÷. ðåä.

88

Martin, B. et al. ‘Caloric restriction and intermittent fasting: two potential diets for successful brain aging.’ Ageing Res Rev (2006): 5: 332–353.

89

Keshel, T. E. et al. ‘Exercise training and insulin resistance: a current review.’ J Obes Weight Loss Ther (2015): 5: S 5–003.

90

Kohman, R. A. et al. ‘Voluntary wheel-running reverses age-induced changes in hippocampal gene expression.’ PLOS One (2011): 6: e22654.

91

Davis, R. A. H. et al. ‘High-intensity interval training and calorie restriction promote remodeling of glucose and lipid metabolism in diet-induced obesity.’ Am J Physiol Endocrinol Metab (2017): 313: E 243–56.

92

Zamir, D. et al, open letter. ‘The tomato genome sequence provides insights into fl eshy fruit evolution.’ Nature (2012): 485: 635–641.

93

Kupferschmidt, K. ‘How tomatoes lost their taste.’ ScienceNOW (28 June 2012). URL: http://news.sciencemag.org/sciencenow/2012/06/how-tomatoes-lost-their-taste.html.

94

Ford, E. et al. ‘Healthy living is the best revenge. Findings from the European prospect-ive investigation into cancer and nutrition – the Potsdam study.’ Arch Intern Med (2009): 169: 1355–1362.

95

Ibid.

96

Goodman, S. ‘Commonalities amongst centenarians.’ The Centenarian (2015).

97

‘Jeanne Calment, World’s Elder, Dies at 122.’ The New York Times (5 August 1997).

98

Lumeng, C. et al. ‘Inflammatory Links Between Obesity and Metabolic Disease.’ J Clin Invest (2011): 121: 2111–2117.

99

Santos-Lozano, A. et al. ‘Implications of Obesity in Exceptional Longevity.’ Ann Transl Med (2016): 4: 416.

100

Centers for Disease Control and Prevention. ‘Top 1 °Causes of Death in the United States from 1900–2010.’

101

‘Comprehensive Health Study in India Finds Rise of Non-communicable Diseases.’ IHME (2017). URL: http://www.healthdata.org/news-release/comprehensive-health-study-india-finds-rise-non-communicable-diseases.

102

Heron, M. ‘Deaths: Leading Causes for 2015.’ National Vital Statistics Reports (2017): 66 (5).

103

Bauer, U. E. et al. ‘Prevention of Chronic Disease in the 21st Century: Elimination of the Leading Preventable Causes of Premature Death and Disability in the USA.’ The Lancet (2014): 384: 45–52.

104

Mainous, G. et al. ‘Prevalence of Prediabetes in England from 2003 to 2011: Population-based, Cross-sectional Study.’ BMJ Open (2014): Vol. 4: Issue 6.

105

Endemann, D. H. et al. ‘Nitric Oxide, Oxidative Excess and Vascular Complications in Diabetes Mellitus.’ Curr Hypertens Rep (2004): Vol 6: 2: 85–89.

106

Liu, J. et al. ‘A Genetically Defined Model for Human Ovarian Cancer.’ Cancer Res (2004): 64: 1655–1663.

107

Heppner, F. L. et al. ‘Immune Attack: The Role of Inflammation in Alzheimer’s Disease.’ Nat Rev Neurosci (2015): 16: 358–372.

108

De Busk, L. M. ‘Tie2 Receptor Tyrosine Kinase, a Major Mediator of TNFa Induced Angiogenesis in Rheumatoid Arthritis.’ Arthritis Rheum (2003): 48: 9: 2461–2471.

109

Olen, O. et al. ‘Childhood Onset of Inflammatory Bowel Disease and Risk of Cancer: A Swedish Nationwide Cohort Study 1964–2014.’ BMJ (2017): doi: 10:1136/bmj.j3951.

110

Vine, A. K. et al. ‘Biomarkers of Cardiovascular Disease as Risk Factors for Age-related Macular Degeneration.’ Opthalmology (2005): 112: 2076–2080.

111

Fuster, V. and Kelly, B. B. ‘Promoting Cardiovascular Health in the Developing World: A Critical Challenge to Achieve Global Health.’ URL: https://www.ncbi.nlm.nih.gov/pubmed/20945571.

112

Anitschkow, N. N. and Chatalov, S. ‘Über experimentelle Cholesterinsteatose und ihre Bedeutung für die Entstehung einiger pathologischer Prozesse.’ Zentralbl Allg Pathol (1913): 24: 1–9.

113

Keys, A. ‘Coronary Heart Disease in Seven Countries.’ Circulation (1970): 41 (4S 1): 1–198.

114

‘The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease.’ JAMA (1984): 251: 351–364.

115

Endo, A. ‘A Historical Perspective on the Discovery of Statins.’ Proc Jpn Acad Ser B Phys Biol Sci (2010): 86: 484–493.

116

Strandberg, T. et al. ‘Cholesterol Lowering after Participation in the Scandinavian Simvastatin Survival Study 4S.’ European Heart Journal (1997): 18: 11: 1725–1727.

117

Ñì. íàïðèìåð: https://www.cdc.gov/diabetes/statistics/slides/maps_diabetesobesity_trends.pdf.

118

Yerushalmy, Y. and Hilleboe, H. E. ‘Fat in the Diet and Mortality from Heart Disease: A Methodologic Note.’ NY State J Med (1957): 57: 2343–2354.

119

Ridker, P. M. ‘C-Reactive Protein Adds to the Predictive Value of Total and HDL Cholesterol in Determining Risk of First Myocardial Infarction.’ Circulation (1998): 97: 20: 2007–2011.

120

Fonseca, F. A. H. et al. ’High-Sensitivity C-Reactive Protein and Cardiovascular Disease Across Countries and Ethnicities.’ Clinics (2016): 71: 235–242.

121

Tonkin, A. M. et al. ‘Effects of Pravastatin on 3,260 Patients with Unstable Angina: Results from the LIPID Study.’ The Lancet (2000).

122

De Rao, A. ‘To JUPITER and Beyond: Statins, Inflammation and Primary Prevention.’ Critical Care (2010) 14: 310.

123

Ibid.

124

Hippisley-Cox, J., Coupland, C. ‘Unintended Effects of Statins in Men and Women in England and Wales: Population-based Cohort Study Using the QResearch database.’ BMJ (2010): 340: c2197.

125

Pignone, M. et al. ‘Aspirin, Statins or Both Drugs for the Primary Prevention of Coronary Heart Disease Events in Men: A Cost-utility Analysis.’ Ann Intern Med(2006): Vol 144, 5: 326–336.

126

Tavazzi, L. ‘Rationale and Design of the GISSI Heart Failure Trial: A Large Trial to Assess the Effects of N-3 Polyunsaturated Fatty Acids and Rosuvastatin in Symptomatic Congestive Heart Failure.’ Eur J of Heart Fail (2004): 6: 635–641.

127

Harding, S. V. et al. ‘Evidence for Using Alpha-lipoic Acid in Reducing Lipoprotein and Inflammatory-related Atherosclerotic Risk.’ J Diet Suppl (2012): 9: 116–127.

128

Apostolov, E. O. ‘Carbamylated-oxidized LDL: Proatherosclerotic Effects on Endothelial Cells and Macrophages.’ J Atheroscler Thromb (2013): 20: 878–892.

129

Ogawa, K. et al. ‘Increase in the Oxidised Low-density Lipoprotein Level by Smoking, and the Possible Inhibitory Effect of Statin Therapy in Patients with Cardiovascular Disease: A Retrospective Study.’ BMJ Open (2016). URL:: http://bmjopen.bmj.com/content/5/1/e005455.

130

Jacobs, L. et al. ‘Traffic Air Pollution and Oxidised LDL.’ PLoS One (2011): 6. URL: ised LDL.’ PLoS One (2011): 6. URL: https://www.ncbi.nlm.nih.gov/pubmed/21283820.

131

Boushehri, S. N. et al. ‘Effect of Vitamin Supplementation on Serum-Oxidized Low-Density Lipoprotein Levels in Male Subjects with Cardiovascular Disease Risk Factors.’ Iran J Basic Med Sci (2012, July – August): 15 (4): 958–964.

132

Wang, Y. et al. ‘Molecular Mechanism of Glutathione-mediated Protection from Oxidised Low-density Lipoprotein Protein-induced Cell Injury in Human Macrophages: Role of Glutathione Reductase and Glutaredoxin.’ Free Radic Biol Med (2006): 41: 775–785.

133

‘Novartis Phase III CANTOS Study Demonstrates that Targeting Inflammation ACZ885 Reduces Cardiovascular Risk’ (27 August 2017). URL: https://www.novartis.com/news/media-releases/novartis-phase-iii-cantos-study-demonstrates-targeting-inflammation-acz885.

134

Levine, M. et al. ‘Low Protein Intake is Associated with a Major Reduction in IGF-1, Cancer, and Overall Mortality in the 65 and Younger but Not Older Population.’ Cell Metabolism (2014): 19: 407–417.

135

Bray, G. et al. ‘Dietary Sugar and Body Weight: Have We Reached a Crisis in the Epidemic of Obesity and Diabetes? Health be damned! Pour on the sugar.’ Diabetes Care (2014): 37: 950–956.

136

‘Just How Much Sugar Do Americans Consume? It’s complicated.’ Associated Press (20 September 2016).

137

Ñì. ðåêîìåíäàöèè Àìåðèêàíñêîé àññîöèàöèè êàðäèîëîãîâ: http://www.heart.org/HEARTORG/HealthyLiving/HealthyEating/Nutrition/Added-Sugars_UCM_305858_Article.jsp#.WbIi9q2Q1sM.

138

Wang, Y. ‘The Obesity Epidemic in the United States – Gender, Age, Socioeconomic, Racial/Ethnic, and Geographic Characteristics: A Systematic Review and Meta-Regression Analysis.’ Am J Epidemiol (2007): 29: 6–28.

139

Streib, L. ‘World’s Fattest Countries.’ Forbes (8 February 2007).

140

‘Future Diets: The Global Rise of Obesity’. ODI (2014). URL: https://www.odi.org/opinion/9329-future-diets-global-rise-obesity.

141

French, S. A. et al. ‘Fast-food Restaurant-use Among Women in the Pound of Prevention Study: Dietary, Behavioral and Demographic Correlates.’ Nature (2000): 24: 1353–1359.

142

Ahmed, S. H. et al. ‘Intense Sweetness Surpasses Cocaine Reward.’ PLoS One (2007).

143

Hoebel, B, et al. ‘Sugar and Fat-bingeing Have Notable Dif erences in Addictive-like Behaviour.’ J Nutr (2009): 139: 623–628.

144

Corwin, R. L. et al. ‘Limited Access to a Dietary Fat Option Af ects Ingestive Behavior But Not Body Composition in Male Rats.’ Physiol Behav (1998): 65: 545–553.

145

Hoebel, B, et al. ‘Sugar and Fat-bingeing Have Notable Dif erences in Addictive-like Behaviour’. J Nutr (2009): 139: 623–628.

146

Kearns, C. E. et al. ‘Sugar Industry and Coronary Heart Disease Research: A Historical Analysis of Internal Industry Documents.’ JAMA (2016): 176: 1680–1685.

147

O’Connor, A. ‘How the Sugar Industry Shifted Blame to Fat.’ The New York Times (12 September 2016).

148

Kearns, C. E. et al. ‘Sugar Industry and Coronary Heart Disease Research: A Historical Analysis of Internal Industry Documents.’ JAMA (2016): 176: 1680–1685.

149

O’Connor, A. ‘Study Tied to Food Industry Tries to Discredit Sugar Guidelines.’ The New York Time (19 December 2016).

150

O’Connor, A. ‘Sugar Industry Long Downplayed Potential Harms.’ The New York Times (21 November 2017).

151

‘Independent experts find no grounds for retraction of BMJ article on dietary guidelines.’ The BMJ (2 December 2016). Ñì. çàÿâëåíèå BMJ äëÿ ïðåññû: http://www.bmj.com/company/wp-content/uploads/2016/12/the-bmj-US-dietary-correction.pdf.

152

Teicholz, N. The Big Fat Surprise: Why Butter, Meat and Cheese Belong in a Healthy Diet. Simon & Schuster (2014).

153

Dietary guidelines for Americans, 2015–2020. Eighth Edition: https://health.gov/dietaryguidelines/2015/guidelines/.

154

‘Fewer Get Heart Attacks.’ Socialstyrelsen (4 November 2013). URL: http://www.socialstyrelsen.se/nyheter/2013november/farrefarhjartinfarkt.

155

Asmat et al. ‘Diabetes mellitus and oxidative stress – a concise review.’ Saudi Pharm J (2016): 24: 547–553.

156

Fields, S. ‘The Fat of the Land: Do Agricultural Subsidies Foster Poor Health?’ Environ Health Perspect (2004): 112: A820–823.

157

Lopes, M. and Prentice, C. ‘U.S. Corn Syrupmakers Slash Prices to Fend Of Cheap Sugar.’ Reuters (11 November 2013).

158

Younossi, Z. M. et al. ‘Global Epidemiology of Non-Alcoholic Fatty Liver Disease – Meta-Analytic Assessment of Prevalence, Incidence and Outcomes.’ Hepatology (2016): 64: 73–84.

159

Browning, J. D. et al. ‘Prevalence of Hepatic Steatosis in an Urban Population in the United States: Impact of Ethnicity.’ Hepatology (2004): 40 (6): 1387–1395.

160

Samuel, V. T. ‘Fructose-induced Lipogenesis: From Sugar to Fat to Insulin Resistance.’ Trends Endocrinol Metab (2011): 22: 60–65.

161

Lustig, R. Fat Chance: The Hidden Truth About Sugar, Obesity and Disease. Harper Collins (2012).

162

Stout, R. W. ‘Insulin-stimulated Lipogenesis in Arterial Tissue in Relation to Diabetes and Atheroma.’ The Lancet (1968): 2: 7570: 702–703.

163

Steinberg, D. ‘Thematic Review Series: The Pathogenesis of Atherosclerosis. An Interpretive History of the Cholesterol Controversy: Part 11: The Early Evidence Linking Hypercholesterolemia to Coronary Disease in Humans.’ J Lipid Res (2005): 46: 2: 179–190.

164

Mohanty, P. et al. ‘Glucose Challenge Stimulates Reactive Oxygen Species (ROS) Generation by Leucocytes.’ J Clin Endocrinol Metab (2000): 85 (8): 2970–2973.

165

Torres-Leal, F. L. et al. ‘The Role of Infl amed Adipose Tissue in Insulin Resistance.’ Cell Biochem Funct (December 2010): Vol 28: 623–631.

166

Chen, L. et al. ‘Mechanisms Linking Infl ammation to Insulin Resistance.’ Int J Endocrinol (2015): 508409: https://www.hindawi.com/journals/ije/2015/508409/.

167

Semenkovich, C. F. ‘Insulin Resistance and Atherosclerosis.’ J Clin Invest (2006): 116: 1813–1822.

168

Ibid.

169

Acheson, K. J. et al. ‘Metabolic Effects of Caf eine in Humans: Lipid Oxidation or Futile Cycling.’ Am J Clin Nutr (2004): 79: 40–46.

170

Duan, W. ‘Dietary Restriction Normalizes Glucose Metabolism and Brain-Derived Neurotrophic Factor Levels, Slows Disease Progression and Increases Survival in Huntington Mutant Mice.’ Proc Natl Acad Sci USA (4 March 2003): 100: 2911–2916.

171

Cassidy, S. et al. ‘High-intensity Interval Training: A Review of its Impact on Glucose Control and Cardiometabolic Health.’ Diabetologia (2017): 60: 7–23.

172

Lee, C. ‘Dietary Restriction with and without Caloric Restriction for Healthy Aging.’ Faculty Review (2016). URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4755412/.

173

Mengmeng, L. V. et al. ‘Roles of Caloric Restriction, Ketogenic Diet and Intermittent Fasting during Initiation, Progression and Metastasis of Cancer in Animal Models: A Systematic Review and Meta-Analysis.’ PLoS One (2014): 9 (12): e115147.

174

Dhabhi, J. M. et al. ‘Identification of Potential Caloric Restriction Mimetic by Microarray Profiling.’ Physiol Genomics (2005): 23: 343–350.

175

Anisimov, V. N. et al. ‘Metformin Slows Down Ageing and Extends Lifespan of Female SHR Mice.’ Cell Cycle (2008): 1: 2769–2773.

176

Johnston, B. C. et al. ‘Comparison of Weight Loss Among Named Diet Programs in Overweight and Obese Adults: A Meta-analysis.’ JAMA (2014): 312: 923–933.

177

Astrup, A. et al. ‘Atkins and Other Low Carbohydrate Diets: Hoax or an Effective Tool for Weight Loss?’ The Lancet (2004): 364: 897–899.

178

Hooper, L. et al. ‘Reduced or Modified Dietary Fat for Preventing Cardiovascular Disease.’ The Cochrane Library (May 2012).

179

Chowdrey, R. et al. ‘Association of Dietary, Circulating and Supplemental Fatty Acids with Coronary Risk.’ Ann Intern Med (2014): 160: 398–406.

180

Sacks, F. M. et al. ‘Dietary Fats and Cardiovascular Disease: A Presidential Advisory From the American Heart Association.’ (2017): 136: http://circ.ahajournals.org/content/early/2017/06/15/CIR.0000000000000510.

181

Teicholz, N. (Op-Ed). ‘Don’t Believe the American Heart Assn. – Butter, Steak and Coconut Oil Aren’t Likely to Kill You.’ Los Angeles Times (23 July 2017). URL: http://www.latimes.com/opinion/op-ed/la-oe-teicholz-saturated-fat-wont-kill-you-20170723-story.html.

182

Dehghan, M. et al. ‘Associations of Fats and Carbohydrate Intake with Cardiovascular Disease and Mortality in 18 Countries from Five Continents (PURE): A Prospective Cohort study.’ The Lancet (August 2017). URL: http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(17)32252-3/fulltext.

183

Grogger, J. ‘Soda Taxes and the Prices of Sodas and Other Drinks: Evidence from Mexico.’ Am J Agric Econ (2017): 99: 481–489.

184

Ñì., íàïðèìåð: http://www.bbc.com/news/health-27961475.

185

Harcombe, Z. ‘An Examination of the Randomized Controlled Trial and Epidemiological Evidence for the Introduction of Dietary Fat Recommendations in 1977 and 1983: A Systematic Review and Meta-analysis.’ Columbus Publishing (2016).

186

Dehghan, M. et al. ‘Associations of Fats and Carbohydrate Intake with Cardiovascular Disease and Mortality in 18 Countries from Five Continents (PURE): A Prospective Cohort study.’ The Lancet (August 2017).

187

Office for National Statistics. ‘National Life Tables: 2014 to 2016.’ URL: https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/lifeexpectancies/bulletins/nationallifetablesnitedkingdom/2014to2016.

188

Office for National Statistics. ‘Estimates of the Very Old (including Centenarians): 2002 to 2016.’ URL: https://www.ons.gov.uk/peoplepopulationandcommunity/births-eathsandmarriages/ageing/bulletins/estimatesoftheveryoldincludingcentenarians/2002to2016#main-points.

189

Willcox, B. et al. ‘The Okinawa Centenarian Study.’ J Gerontol A Biol Sci Med Sci (2006): 61: 354.

190

Ñì. òàáëèöó ÃÈ, ñîñòàâëåííóþ ãðóïïîé ó÷åíûõ èç Ãàðâàðäà: https://www.health.harvard.edu/diseases-and-conditions/glycemic-index-and-glycemic-load-for-100-foods.

191

Golay, A. et al. ‘Similar Weight-loss with Low-energy Food Combining or Balanced Diets.’ Int J Obes (2000): 24: 492–496.

192

Smith, G. I. et al. ‘High Protein Intake During Weight-loss Therapy Eliminates the Weight-loss-induced Improvement in Insulin Action in Obese Postmenopausal Women.’ Cell Reports (2016): 17: 849–861.

193

Levine, M. et al. ‘Low Protein Intake is Associated with a Major Reduction in IGF-1, Cancer, and Overall Mortality in the 65 and Younger but Not Older Population.’ Cell Metabolism (2014): 19: 407–417.

194

Freeman, J. M. et al. ‘The Ketogenic Diet: One Decade Later.’ Pediatrics (2007): 119: 535–543.

195

Volek, J et al. ‘Metabolic Characteristics of Keto-adapted Ultra Endurance Runners.’ Metabolism (2016): 65: 100–110.

196

Yancy, W. S. et al. ‘A Low-carbohydrate, Ketogenic Diet to Treat Type-2 Diabetes.’ Nutr Metab (2005): 2: 34.

197

Martin, B. C. et al. ‘Role of Glucose and Insulin Resistance in the Development of Type-2 Diabetes Mellitus: Results of a 25-year Follow-up Study.’ The Lancet (1992): 340: 925–929.

198

Semenkovich, C. F. ‘Insulin Resistance and Atherosclerosis.’ J Clin Invest (2006): 116: 1813–1822.

199

Kraft, J. Diabetes Epidemic & You. Traf ord Publishing (2008).

200

Âîïðîñ ïøåíèöû è àëëåðãèè î÷åíü óâëåêàòåëüíûé, íà ýòó òåìó åñòü õîðîøèå êíèãè. Âîò äâå èç ìîèõ ëþáèìûõ: Wheat Belly êàðäèîëîãà Âèëüÿìà Äýâèñà è Grain Brain íåâðîëîãà Äýâèäà Ïåðëìóòòåðà. (Èçäàíèÿ íà ðóññêîì ÿçûêå: Äýâèñ Âèëüÿì. Ïøåíè÷íûå êèëîãðàììû. Êàê óãëåâîäû ðàçðóøàþò òåëî è ìîçã. Ì., 2015; Ïåðëìóòòåð Äýâèä. Åäà è ìîçã. ×òî óãëåâîäû äåëàþò ñî çäîðîâüåì, ìûøëåíèåì è ïàìÿòüþ. Ì., 2019.)

201

Estruch, R. et al. ‘Primary Prevention of Cardiovascular Disease with a Mediterranean Diet.’ N Engl J Med (2013): 368: 1279–1290.

202

Buettner, D. ‘The Island Where People Forget to Die.’ The New York Times (24 October 2012).

203

‘Top Trends in Prepared Foods 2017: Exploring trends in meat, fish and seafood; pasta, noodles and rice; prepared meals; savory deli food; soup; and meat substitutes.’ Report Buyer (2017). URL: https://www.reportbuyer.com/product/4959853/top-trends-in-prepared-foods-2017-exploring-trends-in-meat-fish-and-seafood-pasta-noodles-and-rice-prepared-meals-savory-deli-food-soup-and-meat-substitutes.html.

204

Holtcamp, W. ‘Obesogens: an environmental link to obesity.’ Environ Health Perspect (2012): 120: a62–a68.

205

‘IARC Monographs evaluate consumption of red meat and processed meat.’ WHO Internat. Agency for Research on Cancer (2015). URL: http://www.iarc.fr/en/media-centre/pr/2015/pdfs/pr240_E.pdf.

206

Orlich, M. J. et al. ‘Vegetarian Dietary Patterns and Mortality in Adventist Health Study 2.’ JAMA (2013): 173: 1230–1238.

207

‘45 and Up Study.’ Saxinstitute. URL: https://www.saxinstitute.org.au/our-work/45-up-study/.

208

Craig, W. J. ‘Nutritional concerns and health effects of vegetarian diets.’ Nutr Clin Pract (2010): 25: 613–620. URL: https://www.ncbi.nlm.nih.gov/pubmed/21139125.

209

Rosell, M. S. et al. ‘Long-chain n-3 polyunsaturated fatty acids in plasma in British meat-eating, vegetarian, and vegan men.’ Am J Clin Nutr (2005): 82: 327–334. URL: https://academic.oup.com/ajcn/article/82/2/327/4862944.

210

Hirata, Y. et al. ‘Trans-fatty acids promote pro-inflammatory signaling and cell death by stimulating the apoptosis signal-regulating kinase 1 (ASK1)-p38 pathway.’ J Biol Chem (2017). URL: http://www.jbc.org/content/early/2017/03/29/jbc.M116.771519.abstract.

211

Restrepo, B. J. et al. ‘Denmark’s policy on artificial trans fats and cardiovascular disease.’ Am J Prev Med (2016): 50: 59–76.

212

Simonen, P. et al. ‘Cholesterol synthesis is increased and absorption decreased in non-alcoholic fatty liver disease independent of obesity.’ J Hepatol (2011): 54: 153–159.

213

Trappe, T. A. et al. ‘Effect of ibuprofen and acetaminophen on postexercise muscle protein synthesis.’ Am J Physiol Endocrinol Metab (2002): 282: E 551–556.

214

Bowe. W. et al. ‘Acne vulgaris, probiotics and the gut-brain-skin axis – back to the future.’ Gut Pathogens (2011): 3: 1.

215

Holzapfel, W. H. et al. ‘Overview of gut fl ora and probiotics.’ Int J Food Microbiol (1998): 41: 85–101.

216

Beasley, D. E. et al. ‘The evolution of stomach acidity and it’s relevance to the human microbiome.’ PLoS One (2015): 10: e0134116.

217

Dukowicz, A. C. et al. ‘Small Intestinal Bacterial Overgrowth.’ Gastroenterol Hepatol (2007): 3: 112–122.

218

Calton, J. ‘Prevalence of micronutrient deficiency in popular diet plans.’ J Int Soc Sport Nutr (2010): 7: 24.

219

Rose, S. et al. ‘Evidence of oxidative damage and inflammation associated with low glutathione redox status in the autism brain.’ Transl Psychiatry (2012): 2: e134.

220

Dean, O. M. et al. ‘A role for glutathione in the pathophysiology of bipolar disorder and schizophrenia? Animal models and relevance to clinical practice.’ Curr Med Chem (2009): 16: 2965–2976.

221

Bishop, C. ‘A pilot study of the effect of inhaled buf ered reduced glutathione on the clinical status of patients with cystic fibrosis.’ Chest (2005): 127: 308–317.

222

Pizzorno, J. et al. ‘Glutathione.’ Integr Med (2014): 13: 8–12.

223

Noakes, T. and Sboros, M. Lore of Nutrition: Challenging conventional dietary beliefs. Penguin Random House (2017), p. 22.

224

Bell, M. et al. ‘A Retrospective Assessment of the London Smog Episode of 1952: the Role of Infl uenza and Pollution.’ Environ Health Perspect 112.1 (2004): 6–8.

225

‘Seven million premature deaths annually linked to air pollution.’ World Health Organization press release (2014): http://www.who.int/mediacentre/news/releases/2014/air-pollution/en/

226

Azevedo, B. F. et al. ‘Toxic Effects of Mercury on the Cardiovascular and Central Nervous Systems.’ J Biomed Biotechnol (2012): doi: 10.1155/2012/949048.

227

‘Cancer and Toxic Chemicals.’ Physicians for Social Responsibility (2010). URL: http://www.psr.org/environment-and-health/environmental-health-policy-institute/responses/environmental-and-occupational-toxicants-and-cancer.html.

228

McNeill, J. R. Something New Under the Sun: An Environmental History of the Twentieth-Century World New York: Norton, xxvi, 421 pp. (2001).

229

‘Blood Lead Levels Keep Dropping; New Guidelines Recommended for Those Most Vulnerable.’ CDC (1997). URL: https://www.cdc.gov/media/pressrel/lead.htm.

230

Shy, C. M. ‘Lead in Petrol: The Mistake of the XXth Century.’ World Health Stat Q (1990): 43: 168–176.

231

Waalkes, M. P. ‘Cadmium Carcinogenesis in Review.’ J Inorg Biochem (2000): 79: 241–244.

232

Xue, J. ‘Methyl-Mercury Exposure from Fish Consumption in Vulnerable Racial/Ethnic Populations: Probabilistic SHEDS-Dietary Model Analyses Using 1999–2006 NHANES and 1990–2002 TDS Data.’ Sci Total Environ (2012): 373–379.

233

Carson, R. Silent Spring. Houghton Miffl in (1962).

234

‘Organophosphates: A Common But Deadly Pesticide.’ National Geographic (2013).

235

‘Neonicotinoids, Bee Disorders and the Sustainability of Pollinator Services.’ Current Opinion in Environmental Sustainability (2013): 5 (4): 293–305.

236

Goulson, D. ‘Ecology: Pesticides linked to bird declines.’ Nature 511 (2014): 295–296.

237

Gilbert, E. S. ‘Ionising Radiation and Cancer Risks: What We Have Learned from Epidemiology?’ Int J Radiat Biol (2009): 85: 467–482.

238

‘Chernobyl: The True Scale of the Accident.’ WHO (2005). URL: http://www.who.int/mediacentre/news/releases/2005/pr38/en/.

239

Pall, M. L. ‘Scientific Evidence Contradicts Findings and Assumptions of Canadian Safety Panel 6: Microwaves Act Through Voltage-gated Calcium Channel Activation to Induce Biological Impacts at Non-thermal Levels, Supporting a Paradigm Shift for Microwave/Lower Frequency Electromagnetic Field Action.’ Rev Environ Health (2015): 30: 99–116.

240

‘IARC Classifies Radio-frequency Electromagnetic Fields As Possibly Carcinogenic to Humans.’ World Health Organization (May 2011). URL:: http://www.iarc.fr/en/media-centre/pr/2011/pdfs/pr208_E.pdf.

241

Landrigan, P. J. et al. ‘The Lancet Commission on Pollution and Health.’ The Lancet (Oct 2017). URL:: http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(17)32345-0/abstract.

242

Cohen, A. J. et al. ‘Estimates and 25-year Trends of the Global Burden of Disease Attributable to Ambient Air Pollution: An Analysis of Data from the Global Burden of Diseases Study 2015.’ The Lancet (2017). URL: http://dx.doi.org/10.1016/S0140-6736(17)30505-6.

243

Benbrook, C. M. ‘Trends in glyphosate herbicide use in the United States and globally.’ Environ Sci Eur (2016): 28: 3.

244

Wu, J. et al. ‘Alzheimer’s Disease (AD)-Like Pathology in Aged Monkeys after Infantile Exposure to Environmental Metal Lead (Pb): Evidence for a Developmental Origin and Environmental Link for AD.’ J Neurosci (2008): 28: 3–9.

245

‘Tobacco control can save billions of dollars and millions of lives.’ World Health Organization Media Centre (2017). URL: http://www.who.int/mediacentre/news/releases/2017/tobacco-control-lives/en/.

246

‘The Master Settlement Agreement: An Overview.’ The Public Health Law Center (2015). URL: http://publichealthlawcenter.org/sites/default/files/resources/tclc-fs-msa-overview-2015.pdf.

247

West, R. and Fidler, J. ‘Smoking and Smoking Cessation in England 2010: Findings from the Smoking Toolkit Study.’ University College London (2011).

248

For the history of amalgam fillings see, for instance, Rathore, M. et al: ‘The Dental Amalgam Toxicity Fear: A Myth or Actuality.’ Toxicol Int (2012): 19 (2): 81–88.

249

‘The Safety of Dental Amalgam and Alternative Dental Restoration Materials for Patients and Users.’ Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR) (2015). URL: https://ec.europa.eu/health/scientific_committees/emerging/docs/scenihr_o_046.pdf.

250

‘EU Agrees Dental Amalgam Ban in Children, Pregnant and Breastfeeding Women.’ World Alliance for Mercury-Free Dentistry press release (8 December 2016). URL: http://www.eeb.org/index.cfm/library/eu-agrees-dental-amalgam-ban-in-children-pregnant-and-breastfeeding-women/.

251

Séralini, G.-E. et al. ‘Long term toxicity of a Roundup herbicide and a Roundup-tolerant genetically modified maize.’ Food Chem Toxicol, 50 (2012): 50: 4221–4231.

252

Wallace Hayes, A. ‘Editor in Chief of Food and Chemical Toxicology answers questions on retraction.’ Food Chem Toxicol (2014): 65: 394–395.

253

‘Evaluation of Five Organophosphate Insecticides and Herbicides.’ IARC Monographs, Volume 12 (2015). URL:: https://www.iarc.fr/en/media-centre/iarcnews/pdf/MonographVolume112.pdf.

254

‘Conclusion on the Peer Review of the Pesticide Risk Assessment of the Active Substance Glyphosate.’ European Food Safety Authority. EFSA Journal (2015): 13 (11): 4302: DOI: 10.2903/j.efsa.2015.4302.

255

‘Joint FAO/WHO Meeting on Pesticide Residues: Summary Report.’ WHO (16 May 2016). URL: http://www.who.int/foodsafety/jmprsummary2016.pdf.

256

Êàê ïðàâèëî, îöåíèâàþò â êîìïëåêñå ïîêàçàòåëè óðîâíåé ñëåäóþùèõ âåùåñòâ: àëàíèíàìèíîòðàíñôåðàçà, àñïàðòàòàìèíîòðàíñôåðàçà, ùåëî÷íàÿ ôîñôàòàçà, îáùèé áåëîê, àëüáóìèíû, áèëèðóáèí, ãàììàãëóòàìèëòðàíñïåïòèäàçà, ëàêòàòäåãèäðîãåíàçà. Òàêæå îöåíèâàþò ïðîòðîìáèíîâîå âðåìÿ. – Ïðèì. íàó÷. ðåä.

257

Krieg, M. et al. ‘Effect of Aging on Endogenous Level of 5-alpha-Dihydrotestosterone, Testosterone, Estradiol and Estrone in Epithelium and Stroma of Normal and Hyperplastic Human Prostate.’ J Clin Endocrinol Metab (1993): 77 (2): 375–381.

258

Jankowska, E. A. et al. ‘Circulating Estradiol and Mortality in Men with Systolic Chronic Heart Failure.’ JAMA (2009): 301 (18): 1892–1901.

259

Abbott, R. D. et al. ‘Serum Estradiol and Risk of Stroke in Elderly Men.’ Neurology (2007): 68 (8): 563–568.

260

Klaiber, E. L. et al. ‘Serum Estrogen Levels in Men with Acute Myocardial Infarction.’ Am J Med (1982): 73 (6): 872–881.

261

Krieg, M. et al. ‘Effect of Aging on Endogenous Level of 5-alpha-Dihydrotestosterone, Testosterone, Estradiol and Estrone in Epithelium and Stroma of Normal and Hyperplastic Human Prostate.’ J Clin Endocrinol Metab (1993): 77 (2): 375–381.

262

Mauvais-Jarvis, P. et al. ‘Inhibition of Testosterone Conversion to Dihydrotestosterone in Men Treated Percutaneously by Progesterone.’ J Clin Endocrinol Metab (1974): 38 (1): 142–147.

263

Ibid.

264

Browning, J. D. et al. ‘Prevalence of Hepatic Steatosis in an Urban Population in the United States: Impact of Ethnicity.’ Hepatology (2004): 40 (6): 1387–1395.

265

Sanna, C. et al. ‘Non-Alcoholic Fatty Liver Disease and Extra-hepatic Cancers.’ Int J Mol Sci (2016): 17: 717.

266

Nseir, W. et al. ‘Relationship Between Non-Alcoholic Fatty Liver Disease and Breast Cancer.’ Isr Med Assoc J (2017): 19: 242–5. Paschos, P. and Paletas, K. ‘Non-Alcoholic Fatty Liver Disease and Metabolic Syndrome.’ Hippokratia (2009): 13 (1): 9–19.

267

Browning, J. D. et al. ‘Prevalence of Hepatic Steatosis in an Urban Population in the United States: Impact of Ethnicity.’ Hepatology (2004): 40 (6): 1387–1395.

268

Younossi, Z. M. et al. ‘Global Epidemiology of Non-Alcoholic Fatty Liver Disease-Meta-Analytic Assessment of Prevalence, Incidence and Outcomes.’ Hepatology (2016): 64: 73–84.

269

Zhang, Q. Q. et al. ‘Non-Alcoholic Fatty Liver Disease: Dyslipidaemia, Risk for Cardiovascular Complications and Treatment Strategy.’ J Clin Transl Hepatol (2015): 3: 78–84.

270

Ballestri, S. et al. ‘Risk of Cardiovascular, Cardiac and Arrhythmic Complications in Patients with Non-Alcoholic Fatty Liver Disease.’ World J Gastroenterol (2014): 20 (7): 1724–1745.

271

Bailey, R. et al. ‘Unmetabolized Serum Folic Acid and Its Relation to Folic Acid Intake from Diet and Supplements in a Nationally Representative Sample of Adults Aged > or = 60y in the United States.’ Am J Clin Nutr (2010): 92: 383–389.

272

Andreoli, V. and Sprovieri, F. ‘Genetic Aspects of Susceptibility to Mercury Toxicity: An Overview.’ Int J Environ Res Public Health (2017): 14: 93.

273

Rush, T. et al. ‘Effects of Chelation on Mercury, Iron & Lead Neurotoxicity.’ Neurotoxicology (2009): 47–51.

274

Dutczak, W. J. and Ballatori, N. ‘Transport of the Glutathione-Methylercury Complex Across Liver Canalicular Membranes on Reduced Glutathione Carriers.’ J Biol Chem (1994): 269: 9746–9751.

275

Kaur, P. et al. ‘Glutathione Modulation Influences Methylmercury-induced Neurotoxicity in Primary Cell Cultures of Neurons and Astrocytes.’ NeuroToxicology (2006): 27 (4): 492–500.

276

Kane, P. et al. The Detoxx Book: Detoxification of Biotoxins in Chronic Neurotoxic Syndromes (2009).

277

Anand, P. et al. ‘Cancer is a Preventable Disease that Requires Major Lifestyle Changes.’ Pharm Res (2008): 25: 2097–2116.

278

Singh, S. Fermat’s Last Theorem. Fourth Estate (1997).

279

Bianconi, E., et al. ‘An estimation of the number of cells in the human body.’ Ann Hum Biol, November – December 2013, Vol. 40, No. 6: p. 463–471.

280

The Centers for Disease Control and Prevention’s National Center for Health Statistics. Life Expectancy by Age, National Vital Statistics Reports (2011). http://www.cdc.gov/nchs.

281

Steele, E. M. et al. ‘Ultra-Processed Foods and Added Sugars in the US Diet: Evidence from a Nationally Representative Cross-Sectional Study.’ BMJ Open (2016): URL: http://dx.doi.org/10.1136/bmjopen-2015-009892.

282

Menke, A. et al. ‘Prevalence of and Trends in Diabetes Among Adults in the United States, 1988–2012.’ JAMA (2015): 314 (10): 1021–1029. Reference: doi:10.1001/jama.2015.10029.

283

Orentreich, N. et al. ‘Age Changes and Sex Differences in Serum Dehydroepiandrosterone Sulfate Concentrations Throughout Adulthood.’ J Clin Endocrinol Metab (1984): 59: 551–555.

284

Sarrel, P. M. et al. ‘The mortality toll of oestrogen avoidance: an analysis of excessive deaths among hysterectomized women aged 50 to 59 years.’ Am J Public Health (2013): 103: 1583–1588.

285

Mazat, L. et al. ‘Prospective measurements of dehyrdoepiandrostenone sulphate in a cohort of elderly subjects: relationship to gender, subjective health, smoking habits, and 10-year mortality.’ Proc Natl Acad Sci USA (2001): 98: 8145–8150.

286

Zoladz, J. A. et al. ‘The effect of physical activity on the brain derived neurotrophic factor: from animal to human studies.’ J Physiol Pharmacol (2010): 61: 533–541.

287

Piasecki, M. et al. ‘Age-related neuromuscular changes affecting human vastus later-alis.’ J Physiol (2016): 594: 4525–4536.

288

Little, J. P. et al. ‘A practical model of low-volume high-intensity interval training induces mitochondrial biogenesis in human skeletal muscle: potential mechanisms.’J Physiol (2010): 588: 1011–1022.

289

Souza-Teodoro, L. H. et al. ‘Higher serum dehydroepiandrosterone sulfate protects against the onset of depression in the elderly: Findings from the English Longitudinal Study of Ageing (ELSA).’ Psychoneuroendocrinology (2016): 64: 40–46.

290

Ravaglia, G. et al. ‘Determinants of Functional Status in Healthy Italian Nonagenarians and Centenarians: A Comprehensive Functional Assessment by the Instruments of Geriatric Practice.’ J Am Geriatr Soc (1997): 45: 10: 1196–1202.

291

Ibid.

292

Jopp, D. S. et al. ‘Physical, Cognitive, Social and Mental Health in Near-Centenarians and Centenarians Living in New York City: Findings from the Fordham Centenarian Study.’ BMC Geriatr (2016): 16: 1.

293

Buettner, D. The Blue Zones: Lessons for Living Longer from the People Who’ve Lived the Longest. National Geographic (2010). (Èçäàíèå íà ðóññêîì ÿçûêå: Áþòòíåð Äýí. Ãîëóáûå çîíû. 9 ïðàâèë äîëãîëåòèÿ îò ëþäåé, êîòîðûå æèâóò äîëüøå âñåõ. Ì., 2015.)

294

Òðè îñíîâíûõ BCAA – ýòî âàëèí, ëåéöèí è èçîëåéöèí. Îíè ñîäåðæàòñÿ â ìÿñå, ðûáå, ìîëî÷íûõ ïðîäóêòàõ è ÿéöàõ, à òàêæå â áîáàõ, ÷å÷åâèöå è îðåõàõ. – Ïðèì. àâòîðà.

295

Maynial-Denis, D. ‘Glutamine Metabolism in Advanced Ageing.’ Nutr Rev (2016): 74: 225–236.

296

Kloek, J. et al. ‘Glutathione Prevents the Early Asthmatic Reaction and Airway Hyperresponsiveness in Guinea Pigs.’ J Physiol Pharmacol (2010): 61: 67–72.

297

Jeevanandam, M. et al. ‘Altered Plasma Cytokines and Total Glutathione Levels in Parenterally Fed Critically Ill Trauma Patients with Adjuvant Recombinant Human Growth Hormone (rhGH) Therapy.’ Crit Care Med (2000): 28: 2: 324–329.

298

Christensen, K. et al. ‘The Quest for Genetic Determinants of Human Longevity: Challenges and Insights.’ Nat Rev Genet (2006): 7: 436–448.

299

Liu, H. et al. ‘Systematic Review: The Safety and Efficacy of Growth Hormone in the Healthy Elderly.’ Ann Intern Med (2007): 146: 104–105.

300

Liu, H. et al. ‘Systematic Review: The Safety and Efficacy of Growth Hormone in the Healthy Elderly.’ Ann Intern Med (2007): 146: 104–105.

301

‘Analysis of Faulty Data Yields Inaccurate Results: Thousands Benefit from Growth Hormone Replacement Therapy for Aging-Related Disorders – Proven, Real-World Track Record of Benefits of Adult Growth.’ Worldhealth.net (15 January 2007), A4M in the Media. URL: http://www.worldhealth.net/news/analysis_of_faulty_data_yields_inaccurat/.

302

Brown-Borg, H. M. et al. ‘Life Extension in the Dwarf Mouse.’ Curr Top Dev Biol (2004): 63: 189–225.

303

Bartke, A. et al. ‘Does growth hormone prevent or accelerate aging?’ Exp Gerontol (1998): 33: 675–687.

304

Clancy, D. J. et al. ‘Extension of life-span by loss of CHICO, a Drosophila insulin receptor substrate protein.’ Science (2001): 292: 104–106.

305

Patronek, G. J. et al. ‘Comparative Longevity of Pet Dogs and Humans: Implications for Gerontology Research.’ J Gerontol A Biol Sci Med Sci (1997): 52A: B 171–178.

306

Besson, A. et al. ‘Reduced Longevity in Untreated Patients with Isolated Growth Hormone Deficiency.’ J Clin Endocrinol Metab (2003): 88: 80: 3664–3667.

307

Guevara-Aguirre, J. et al. ‘Growth Hormone Receptor Deficiency is Associated with a Major Reduction in Pro-aging Signaling, Cancer and Diabetes in Humans.’ Sci Transl Med (2011): 3 (70): 70.

308

Shevah, O., Laron, Z. ‘Patients with Congenital Deficiency of IGF-I Seem Protected from the Development of Malignancies: A Preliminary Report.’ Growth Horm IGF Res (2007): 17: 54–57.

309

Shechter, M. et al. ‘Obese Adults with Primary Growth Hormone Resistance (Laron Syndrome) have Normal Endothelial Function.’ Growth Horm IGF Res (2007): 17: 165–170.

310

Milman, S. et al. ‘Low Insulin-Like Growth Factor 1 Level Predicts Survival in Humans with Exceptional Longevity.’ Aging Cell (12 March 2014). http://onlinelibrary.wiley.com/doi/10.1111/acel.12213/full.

311

Orme, S. M. et al. ‘Mortality and Cancer Incidence in Acromegaly: A Retrospective Cohort Study.’ J Clin Endocrinol Metab (1998): 83: 2730–2734.

312

Sacca, L. et al. ‘Growth Hormone, Acromegaly and Heart Failure: An Intricate Triangulation.’ Clin Endocrinol (2003): 59: 660–671.

313

Vergara, M. et al. ‘Hormone-Treated Snell Dwarf Mice Regain Fertility But Remain Long Lived and Disease Resistant.’ J Gerontol A Biol Sci Med Sci (2004): 59: 1244–1250.

314

Panici, J. et al. ‘Early Life Growth Hormone Treatment Shortens Longevity and Decreases Cellular Stress Resistance in Long-lived Mutant Mice.’ FASEB J (2010): 24: 5073–5079.

315

Chrisman, O. D. ‘The Effect of Growth Hormone on Established Cartilage Lesions. A Presidential Address to the Association of Bone and Joint Surgeons, 1974.’ Clin Orthop Relat Res (1975): 107: 232–238.

316

Eto, B. et al. ‘Glutamate-Arginine Salts and Hormonal Responses to Exercise.’ Arch Physiol Biochem (1995): 103: 160–164.

317

Manglik, S. et al. ‘Serum Insulin but not Leptin is Associated with Spontaneous and Growth Hormone (GH)-releasing Hormone Stimulated GH Secretion in Volunteers with and without Weight-loss.’ Metabolism (1998): 47: 1127–1133.

318

Denti, L. et al. ‘Effects of Aging on Dehydroepiandrosterone Sulfate in Relation to Fasting Insulin Levels and Body Composition Assessed by Bioimpedance Analysis.’ Metabolism (1997): 1246–1251.

319

Xu, X. et al. ‘Ethanol Suppresses Growth Hormone-Mediated Cellular Responses in Liver Slices.’ Alcoholism: Clin Exp Res (1995): 19: 1246–1251.

320

Van Cauter, E. et al. ‘Age-related Changes in Slow Wave Sleep and REM Sleep and Relationship with Growth Hormone and Cortisol Levels in Healthy Men.’ JAMA (2000): 284: 861–868.

321

Valenti, G. ‘Neuroendocrine Hypothesis of Ageing: The Role of Corticoadrenal Steroids.’ J Endocrinol Invest (2004): 27: 62–63.

322

Morales, A. J. ‘Effects of Replacement Dose of Dehydroepiandrosterone in Men and Women of Advancing Age.’ J Clin Endocrinol Metab (1994): 1360–1367. Bloch, M. et al. ‘Dehydroepiandrosterone Treatment of Midlife Dysthymia.’ Biol Psychiatry (1999): 45: 1533–1541.

323

Wolkowitz, O. M. et al. ‘Double-blind Treatment of Major Depression with Dehydroepiandrosterone.’ Am J Psychiatry (1999): 156 (4): 646–649. Schmidt, P. et al. ‘Dehydroepiandrosterone Monotherapy in Midlife-Onset Major and Minor Depression.’ Arch Gen Psychiatry (2005): 62: 154–162.

324

Reiter, W. J. et al. ‘DHEA in the Treatment of Erectile Dysfunction. A Prospective, Double-blind, Randomized, Placebo Controlled Study.’ Urology (1999): 53: 590–594.

325

Barrett-Connor, E. et al. ‘Endogenous Levels of Dehydroepiandrosterone Sulfate, But Not Other Sex Hormones, are Associated with Depressed Mood in Older Women: the Rancho Bernardo Study.’ J Am Geriatr Soc (1999): 47: 685–691.

326

Bastianetto, S. et al. ‘Dehydroepiandrosterone (DHEA) Protects Hippocampal Cells from Oxidative Stress-induced Damage.’ Mol Brain Res (1999): 66: 35–41.

327

Alhaj, H. A. et al. ‘Effects of DHEA Administration on Episodic Memory, Cortisol and Mood in Healthy Young Men: A Double-blind, Placebo-controlled Study.’ Psychopharmacology (2006): 188: 541–551.

328

Roth, G. et al: ‘Global and National Cardiovascular Disease Prevalence, Mortality, and Disability-Adjusted Life-Years for 1 °Causes, 1990 to 2015.’ J Am Coll Cardiol (May 2017).

329

Feldman, H. et al. ‘Low Dehydroepiandrosterone Sulfate and Heart Disease in Middle-Aged Men: Cross-Sectional Results from the Massachusetts Male Aging Study.’ AEP (1998): 8217–8228.

330

Fukui, M. et al. ‘Serum Dehydroepiandrosterone Sulfate Concentration and Carotid Atherosclerosis in Men with Type-2 Diabetes.’ Atherosclerosis (2005): 181: 339–344.

331

Yoshida, S. et al. ‘Dehydroepiandrosterone Sulfate is Inversely Associated with Sex-Dependent Diverse Carotid Atherosclerosis Regardless of Endothelial Function.’ Atherosclerosis (2010): 212: 310–315.

332

Okamoto, K. ‘Relationship Between Dehydroepiandrosterone Sulfate and Serum Lipid Levels in Japanese Men.’ J Epidemiol (1996): 6: 63–67.

333

Nestler, J. et al. ‘Dehydroepiandrosterone Reduces Serum Low Density Lipoprotein Levels and Body Fat but Does not Alter Insulin Sensitivity in Normal Men.’ J Clin Endocrinol Metab (1988): 66: 57–61.

334

Jimenez, M. et al. ‘Low Dehydroepiandrosterone Sulphate is Associated with Increased Risk of Ischemic Stroke Among Women.’ Stroke (2013): 44. URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3811081/.

335

Fulop, T. et al. ‘Relationship Between the Response to Influenza Vaccination and the Nutritional Status in Institutionalized Elderly Subjects.’ J Gerontol Biol Sci (1999): 54: M59–64.

336

Khorram, O. et al. ‘Activation of Immune Function by Dehydroepiandrosterone (DHEA) in Age-advanced Men.’ J Gerontol A Biol Sci Med Sci (1997): 52 (1): M1–7.

337

Goh, J. et al. ‘Exposure To Harmful Workplace Practices Could Account For Inequality In Life Spans Across Different Demographic Groups.’ Health Affairs (2015): 34: 1761–1768.

338

Hara, M. R. et al. ‘A Stress Response Pathway Regulates DNA Damage Through β-2-Adrenoreceptors and β-Arrestin-1.’ Nature (2011): 477: 349–353.

339

Phillips, A. et al. ‘Cortisol, DHEA Sulphate, Their Ratio and All-cause and Cause-specific Mortality in the Vietnam Experience Study.’ Eur J Endocrinol (2010): 163: 285–292.

340

Berk, M. et al. ‘N-acetylcysteine for Depressive Symptoms in Bipolar Disorder. A Randomised Placebo-controlled Trial.’ Biol Psychiatry (2008): 64, 6: 468–475.

341

Cerami, A. et al. ‘Glucose and Aging.’ Sci Am (1987): 256: 90–96.

342

Smith, M. A. et al. ‘Advanced Maillard Reaction End Products are Associated with Peroxisome Proliferations.’ Chem Biol Interact (1999): 1–3: 205–218.

343

Bierhaus, A. et al. ‘Advanced Glycation End Product-Induced activation of NF Kappa B is Suppressed by Alpha-lipoic Acid in Cultured Endothelial Cells.’ Diabetes (1997): 47: 1481–1490.

344

Asgary, S. et al. ‘Antioxidant Effects of Flavonoids on Haemoglobin Glycosylation.’ Pharm Acta Helv (1999): 73: 223–226.

345

Song, D. et al. ‘Chronic N-acetylcysteine Prevents Fructose-induced Insulin Resistance and Hypertension in Rats.’ Eur J Pharmacol (2005): 508: 205–210.

346

Masha, A. et al. ‘Prolonged Treatment with N-acetylcysteine and L-arginine Restores Gonadal Function in Patients with PCO Syndrome.’ J Endocrinol Invest (2009). Nakagawa, T. et al. ‘Protective Activity of Green Tea Against Free Radical and Glucose Mediated Protein Damage.’ J Agric Food Chem (2002): 50: 2418–2422.

347

Koschinsky, T. et al. ‘Orally-absorbed Reactive Glycation Products (Glycotoxins): An Environmental Risk Factor in Diabetic Nephropathy.’ Proc Natl Acad Sci USA (1997): 94: 6474–6479.

348

Halvorsen, B. L. et al. ‘Determination of Lipid Oxidation Products in Vegetable Oils and Marine Omega-3 Supplements.’ Food Nutr Res (2011): 55.

349

Boor, P. et al. ‘Regular Moderate Exercise Reduces Advanced Glycation and Ameliorates Early Diabetic Nephropathy in Obese Zucker Rats.’ Metabolism (2009): 58: 1669–1677.

350

Flatley, J. ‘The nature of violent crime in England and Wales: year ending March 2017.’ The Oice of National Statistics.

351

Salleh, R. M. ‘Life event, stress and illness.’ Malays J Med Sci (2008): 15: 9–18.

352

Sapolsky, R. M. Why Zebras Don’t Get Ulcers: An Updated Guide to Stress, Stress-Related Diseases and Coping. W. H. Freeman (1994).

353

Lowe, S. et al. ‘Control of Apoptosis by p53.’ Oncogene (2003): 22: 9030–9040.

354

Makoto, R. et al. ‘A Stress Response Pathway Regulates DNA Damage Through B 2-adrenoreceptors and B-arrestin.’ Nature (online): 21 August 2011.

355

Misra, M. et al. ‘Higher Cortisol Associated with Greater Visceral Adiposity.’ Am J Physiol Endocrinol Metab (2008): 295 (2).

356

Straub, R. et al. ‘Inadequately Low Serum Levels of Steroid Hormones in Relation to IL6 and Tumour Necrosis Factor in Untreated Patients with Early Rheumatoid Arthritis.’ Arthritis Rheum (2002): 654–662.

357

Khani, S. et al. ‘Cortisol Increases Glucose-Genesis in Humans: Its Role in the Metabolic Syndrome.’ Clinical Sciences (2001): 101: 739–747.

358

Dhabhar, F. S. et al. ‘Acute Stress Enhances While Chronic Stress Suppresses Cell-Mediated Immunity In Vivo: A Potential Role for Leukocyte Traicking.’ Brain Behav Immun (1997): 11 (4): 286–306.

359

Reiche, E. M. V. et al. ‘Stress, Depression, the Immune System and Cancer.’ Lancet Oncol (2004): 5: 617–625.

360

Jeferies, W. M. Safe Uses of Cortisol. Charles C. Thomas Pub Ltd, 3rd Ed (2004), pp. 3–9.

361

Hench, P. S. et al. ‘The Effect of a Hormone of the Adrenal Cortex on Rheumatoid Arthritis.’ Preliminary Report. Proc Staf Meet, Mayo Clinic (1949): 24: 181–197.

362

Jeferies, W. M. Safe Uses of Cortisol. Charles C. Thomas Pub Ltd, 3rd Ed (2004), pp. 3–9.

363

Jeferies, W. M. ‘Low-Dosage Glucocorticoid Therapy.’ Arch Intern Med (1967): 119: 265–278.

364

Steptoe, A, et al. ‘Depression and Elevated Cortisol.’ Am J Epidemiol (2008): 167 (1): 96–102.

365

Lupien, S. et al. ‘The Douglas Hospital Longitudinal Study of Normal and Pathological Ageing.’ J Psych of Neuroscience (2005): 30: 328–334.

366

Swaab, D. F. et al. ‘Elevated Cortisol in Rats Induces Neuronal Damage.’ Ageing Res Rev (2005): 4 (2): 141–194.

367

Stenius, F. et al. ‘Salivary Cortisol Levels and Allergy in Children: the ALADDIN Birth Cohort.’ J Clin Immune (2011).

368

Hedman, M. et al. ‘Low Blood and Synovial Fluid Levels of Conjugated Steroids in Rheumatoid Arthritis.’ Clin Exp Rheumatol (1992) 10: 25–30.

369

Strickland, P. et al. ‘A Comparison of Salivary Cortisol in Chronic Fatigue Syndrome, Community Depression and Healthy Controls.’ Journal of Af ective Disorders (1998): 47: 191–194.

370

Dunkelmann, S. S. et al. ‘Cortisol Metabolism in Obesity.’ J Clin Endocrinol Metab (1964): 24: 832–841.

371

Szafarczyk, A. et al. ‘Further Evidence for a Central Stimulatory Action of Catecholamines on Adrenocorticotropin Release in the Rat.’ Endocrinology (1987): 121 (3): 121.

372

Figueiro, M. and Rea, M. S. ‘The Effects of Red and Blue Light on Circadian Variations in Cortisol, Alpha Amylase, and Melatonin.’ International Journal of Endocrinology (2010): ID 829351.

373

Jung, H. J. et al. ‘Effect of Testosterone Replacement Therapy on Cognitive Performance and Depression in Men with Testosterone Deficiency Syndrome.’ World J Men’s Health (2016): 34: 194–199.

374

Arlt, W. et al. ‘DHEA replacement in women with adrenal insui ciency – pharmacokinetics, bioconversion and clinical effects on well-being, sexuality and cognition.’ Endocrine Research (2000): 26: 505–511. URL: http://www.tandfonline.com/doi/abs/10.3109/07435800009048561.

375

Sarrel, P. M. et al. ‘The mortality toll of oestrogen avoidance: an analysis of excessive deaths among hysterectomized women aged 50 to 59 years.’ Am J Public Health (2013): 103: 1583–1588.

376

Basaria, S. et al. ‘Adverse events associated with testosterone administration.’ N Engl J Med (2010): 363 (2): 109–122.

377

Levine, H. et al. ‘Temporal Trends in Sperm Count: A Systematic Review and Meta-Regression Analysis.’ Hum Reprod Update (2017): 1–14.

378

‘Ageing and health.’ World Health Organization. http://www.who.int/mediacentre/factsheets/fs404/en/.

379

Vermeulen, A. et al. ‘The apparent free testosterone concentration: An index of androgenicity.’ J Clin Endocrinol Metab (1971): 33: 759–767.

380

Kaufman, J. M. et al. ‘Androgens in male senescence.’ In Nieschlag, E., Behre, H. M. eds. Testosterone action, deficiency, substitution. Berlin, Springer-verlag (1998): 437–471. Liefke, E. et al. ‘Age-related changes of serum sex hormones, insulin-like growth factor-1 and SHBG levels in men: cross-sectional data from a healthy male cohort.’ Clin Endocrinol (Oxford) (2000): 53: 689–695.

381

Stellato, R. K. et al. ‘Testosterone, SHBG and the development of type-2 diabetes in middle-aged men: prospective results from the Massachusetts Male Ageing Study.’ Diabetes Care (2000): 23: 490–494.

382

Mof at, S. D. et al. ‘Longitudinal assessment of serum free testosterone concentration predicts memory performance and cognitive status in elderly men.’ J Clin Endocrinol Metab (2002): 87: 5001–5193.

383

Mof at, S. D. et al. ‘Free testosterone and risk for Alzheimer’s disease in older men.’ Neurology (2004): 62: 188–193. Braga-Basaria, M. et al. ‘Metabolic syndrome in med with prostate cancer undergoing long-term androgen deprivation therapy.’ J Clin Oncol (2006): 24: 3979–3983.

384

Selvin, E. et al. ‘Androgens and diabetes in men: results from the third National Health and Nutrition Examination Survey (NAHANES III).’ Diabetes Care (2007): 30: 234–238.

385

Rosano, G. M. et al. ‘Low testosterone levels are associated with coronary artery disease in male patients with angina.’ Int J Impot Res (2007): 19: 176–182.

386

Khaw, K. T. et al. ‘Endogenous testosterone and mortality due to all causes, cardiovascular disease and cancer in men. EPIC-Norfolk prospective population study.’ Circulation (2007): 116: 2694–2701.

387

Malkin, C. J. et al. ‘The effect of testosterone replacement on endogenous infl ammatory cytokines and lipid profiles in hypogonadal men.’ J Clin Endocrinol Metab (2004): 89: 3313–3318.

388

Oppenheim, D. S. et al. ‘Elevated serum lipids in hypogonadal men with and without hyperprolactinaemia.’ Ann Intern Med (1989): 111: 288–292.

389

Hanke, H. et al. ‘Effect of testosterone on plaque development and androgen receptor expression in the arterial vessel wall.’ Circulation (2001): 103: 1382–1385.

390

Malkin, C. J. et al. ‘The effect of testosterone replacement on endogenous infl ammatory cytokines and lipid profiles in hypogonadal men.’ J Clin Endocrinol Metab (2004): 89: 3313–3318.

391

Rubinow, K. B. et al. ‘Testosterone replacement in hypogonadal men alters the HDL proteome but not HDL cholesterol el ux capacity.’ J Lipid Res (2012): 53: 1376–1383. Nettleship, J. E. et al. ‘Physiological testosterone replacement therapy attenuates fatty streak formation and improves high density lipoprotein cholesterol in the Tfm mouse.’ Circulation (2007): 116: 2427–2434.

392

Hanke, H. et al. ‘Effect of testosterone on plaque development and androgen receptor expression in the arterial vessel wall.’ Circulation (2001): 103: 1382–1385.

393

Hackett, G. et al. ‘Testosterone replacement therapy improves metabolic parameters in hypogonadal men with type 2 diabetes but not in men with coexisting depression: the BLAST study.’ J Sex Med (2014): 11: 840–856.

394

Dhinsa, S. et al. ‘Insulin Resistance and Infl ammation in Hypogonadotropic Hypogonadism and Their Reduction After Testosterone Replacement in Men With Type 2 Diabetes.’ Diabetes Care (2016): 39: 82–91.

395

Cherrier, M. M. et al. ‘Testosterone improves spatial memory in men with Alzheimer’s disease and mild cognitive impairment.’ Neurology (2005): 64: http://n.neurology.org/content/64/12/2063.full.

396

Vigen, R. et al. ‘Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels.’ JAMA (2013): 310: 1829–1836.

397

Finkle, W. D. et al. ‘Increased risk of nonfatal myocardial infarction following testosterone therapy prescription in men.’ PLoS One (2014): 9.

398

Patel, P., Arora, B., Molnar, J., et al. ‘Effect of testosterone therapy on adverse cardiovascular events among men: A meta-analysis.’ American College of Cardiology 2015 Scientific Sessions (15 March 2015).

399

Corona, G. et al. ‘Testosterone replacement therapy and cardiovascular risk: a review.’ World J Men’s Health (2015): 33: 130–142.

400

Cheetham, T. C. et al. ‘Association of testosterone replacement with cardiovascular outcomes among men with androgen deficiency.’ JAMA (2017): 177: 491–499.

401

Small, M. et al. ‘Oestradiol levels in diabetic men with and without a previous myocardial infarction.’ Q J Med (1987): 64 (243): 617–623.

402

Kirby, E. D. et al. ‘Stress increases putative gonadotropin inhibitory hormone and decreases luteinizing hormone in male rats.’ Proc Natl Acad Sci USA (2009): 106: 11324–11329.

403

Volek, J. S. et al. ‘Testosterone and cortisol in relationship to dietary nutrients and resistance exercise.’ J Appl Physiol (1997): 82 (1): 49–54.

404

Wang, C. et al. ‘Low-fat high-fiber diet decreased serum and urine androgens in men.’ J Clin Endocrinol Metab (2005): 90 (5): 3550–3559.

405

Sadowski, Z. et al. ‘Effect of testosterone replacement therapy on lipids and lipoproteins in hypogonadal and elderly men.’ Atherosclerosis (1996): 121: 35–43.

406

Carruthers, M. Androgen Deficiency in the Adult Male. Taylor & Francis (2004) pp. 51–52.

407

Krieg, M. et al. ‘Effect of aging on endogenous level of 5 alpha dihydrotestosterone, testosterone, Estradiol and Estrone in epithelium and stroma of normal and hyperplastic human prostate.’ J Clin Endocrinol Metab (1993): 77 (2): 375–381.

408

Abbott, R. D. et al. ‘Serum Estradiol and risk of stroke in elderly men.’ Neurology (2007): 68 (8): 563–568.

409

Small, M. et al. ‘Oestradiol levels in diabetic men with and without a previous myocardial infarction.’ Q J Med (1987): 64 (243): 617–623. Phillips, G. B. et al. ‘The association of hypotestosteronemia with coronary artery disease in men.’ Arterioscler Thromb (1994): 14 (5): 701–706.

410

Klaiber, E. L. et al. ‘Serum estrogen levels in men with acute myocardial infarction.’ Am J Med (1982): 73 (6): 872–881.

411

Mellstrom, D. et al. ‘Older men with low serum Estradiol and high serum SHBG have an increased risk of fractures.’ J Bone Miner Res (2008): 23 (10): 1552–1560.

412

 Ðîññèè çàðåãèñòðèðîâàí êàê ïðåïàðàò äëÿ ëå÷åíèÿ ðàêà ìîëî÷íîé æåëåçû ó æåíùèí â ïîñòìåíîïàóçå. Îòïóñêàåòñÿ òîëüêî ïî ðåöåïòó âðà÷à. – Ïðèì. íàó÷. ðåä.

413

Ïðîäàþùèåñÿ â Ðîññèè ãåëè ñ ïðîãåñòåðîíîì â îñíîâíîì (íà èþíü 2020 ãîäà åäèíñòâåííîå èñêëþ÷åíèå – «Ïðîæåñòîæåëü») ïðåäíàçíà÷åíû äëÿ ââåäåíèÿ âî âëàãàëèùå è îòïóñêàþòñÿ òîëüêî ïî ðåöåïòó âðà÷à. – Ïðèì. íàó÷. ðåä.

414

Ïðåïàðàòû íà îñíîâå ôèíàñòåðèäà â Ðîññèè çàðåãèñòðèðîâàíû êàê ñðåäñòâà äëÿ ëå÷åíèÿ äîáðîêà÷åñòâåííîé ãèïåðïëàçèè ïðåäñòàòåëüíîé æåëåçû è îòïóñêàþòñÿ òîëüêî ïî ðåöåïòó âðà÷à. – Ïðèì. íàó÷. ðåä.

415

Ïî ñîñòîÿíèþ íà èþíü 2020 ãîäà ýòîò ïðåïàðàò â Ðîññèè íå çàðåãèñòðèðîâàí. – Ïðèì. íàó÷. ðåä.

416

Prasad, A. S. et al. ‘Zinc status and serum testosterone levels in healthy adults.’ Nutrition (1996): 12: 344–348.

417

Pokrywka, A. et al. ‘Insights into supplements with tribulus terrestris used by athletes.’ J Hum Kinet (2014): 41: 99–105.

418

Kim, C. et al. ‘Changes in visceral adiposity, subcutaneous adiposity and sex hormones in the diabetes prevention program.’ J Clin Endocrinol Metab (2017): 102: 3381–3389.

419

Volek, J. et al. ‘Testosterone and cortisol in relationship to dietary nutrients and resistance exercise.’ J Appl Physiol (1997): 82: 49–54.

420

Ñì., íàïðèìåð, ñàéò Women’s Health Initiative: www.whi.org.

421

 Ðîññèè ãåëü ñ òåñòîñòåðîíîì çàðåãèñòðèðîâàí ïîä íàçâàíèåì «Àíäðîãåëü», îòïóñêàåòñÿ òîëüêî ïî ðåöåïòó âðà÷à. – Ïðèì. íàó÷. ðåä.

422

 Ðîññèè ïî ñîñòîÿíèþ íà èþíü 2020 ãîäà «Äåêà-Äóðàáîëèí» íå çàðåãèñòðèðîâàí. Èìååòñÿ ïðåïàðàò íàíäðîëîíà äåêàíîàò ïîä íàçâàíèåì «Ðåòàáîëèë». – Ïðèì. íàó÷. ðåä.

423

Ïî ñîñòîÿíèþ íà èþíü 2020 ãîäà â Ðîññèè íå çàðåãèñòðèðîâàí. – Ïðèì. íàó÷. ðåä.

424

Frisoli, A. J. et al. ‘The effect of nandrolone decanoate on bone mineral density, muscle mass, and hemoglobin levels in elderly women with osteoporosis: a double-blind, randomized, placebo-controlled clinical trial.’ J Gerontol A Biol Sci Med Sci (2005): 60: 648–653.

425

 Ðîññèè âûïóñêàåòñÿ ïîä ìåæäóíàðîäíûì íåïàòåíòîâàííûì íàèìåíîâàíèåì «Òåñòîñòåðîíà ïðîïèîíàò». – Ïðèì. íàó÷. ðåä.

426

Ïî ñîñòîÿíèþ íà èþíü 2020 ãîäà ïðåïàðàòû òåñòîñòåðîíà àöåòàòà â Ðîññèè íå çàðåãèñòðèðîâàíû. – Ïðèì. íàó÷. ðåä.

427

Ïî ñîñòîÿíèþ íà èþíü 2020 ãîäà ïðåïàðàòû òåñòîñòåðîíà öèïèîíàòà â Ðîññèè íå çàðåãèñòðèðîâàíû. – Ïðèì. íàó÷. ðåä.

428

Herrera, A. Y. et al. ‘Stress-induced increases in progesterone and cortisol in naturally Cycling women.’ Neurobiol Stress (2016): 3: 96–104.

429

Dhabhar, F. S. ‘Enhancing versus Suppressive Effects of Stress on Immune Function: Implications for Immunoprotection versus Immunopathology.’ Allergy Asthma Clin Immunol (2008): 4: 2–11.

430

Hall, O. J. et al. ‘Progesterone-Based Therapy Protects Against Infl uenza by Promoting Lung Repair and Recovery in Females.’ PLoS Pathog (2016): 12: e1005840.

431

Schumacher, M. ‘Local synthesis and dual actions of progesterone in the nervous system: neuroprotection and myelin.’ Growth Horm IGF Res (2004): 14 Suppl a: S 18–33.

432

Stein, D. G. ‘Progesterone exerts neuroprotective effects after brain injury.’ Brain Res Rev (2008): 57 (2): 386–397.

433

Arbo, B. D. et al. ‘Asymmetric effects of low doses of progesterone on GABA(A) receptor α4 subunit protein expression in the olfactory bulb of female rats.’ Can J Physiol Pharmacol (2014): 92: 1–5.

434

Von Broekhoven, F. et al. ‘Neurosteroids in depression: a review.’ Psychopharmacology (2003): 165: 97–110.

435

Sitruk-Ware, R. et al. ‘Progesterone and related progestins: potential new health benefits.’ Climacteric (2013): 16 Suppl 1: 69–78.

436

Nilsen, J. et al. ‘Impact of progestins on estrogen-induced neuroprotection: synergy by progesterone and 19-norprogesterone and antagonism by medroxyprogesterone acetate.’ Endocrinology (2002): 143: 205–212. Boomsma, D. and Paoletti, J. ‘A review on the current research on the effects of progesterone.’ Int J Pharm Compd (July/August 2002): (6) 4.

437

Stein, D. G. ‘The case for progesterone.’ Ann NY Acad Sci (2005): 1052: 152–69.

438

Mauvais-Jarvis, M. et al. ‘Inhibition of testosterone conversion to dihydrotestosterone in men treated percutaneously by progesterone.’ J Clin Endocrinol Metabolism (1974): 38 (1): 142–147.

439

Oettel, M. et al. ‘Progesterone: the forgotten hormone in men?’ The Aging Male (2004): 7: 236–257.

440

Cassidenti, G. L. et al. ‘Effects of sex steroids on skin 5 alpha-reductase activity in vitro.’ Obstet Gynecol (1991): 78: 103–107.

441

Singh, M. K. et al. ‘Persistent Sexual Dysfunction and Depression in Finasteride Users for Male Pattern Hair Loss. A Serious Concern or Red Herring?’ J Clin Aesthet Derm (2014): 7: 51–55.

442

Bhasin, S. et al. ‘Testosterone therapy in adult men with androgen deficiency syndromes: An Endocrine Society clinical practice guideline.’ J Clin Endocrinol Metab (1997): 82: 407–413.

443

‘FDA In Brief: FDA warns against using SARMs in body-building products.’ Press Release FDA (31 October 2017).

444

Mof at, S. D. et al. ‘Longitudinal assessment of serum free testosterone concentration predicts memory performance and cognitive status in elderly men.’ J Clin Endocrinol Metab (2002): 87: 5001–5007.

445

Mof at, S. D. et al. ‘Free testosterone and risk for Alzheimer’s disease in older men.’ Neurology (2004): 62: 188–193.

446

Beer, T. M. et al. ‘Testosterone loss and Estradiol administration modify memory in men.’ J Urol (2006): 175: 130–135.

447

Haider, K. S. et al. ‘Long-Term Testosterone Therapy Improves Urinary and Sexual Function, and Quality of Life in Men with Hypogonadism: Results from a Propensity Matched Subgroup of a Controlled Registry Study.’ J Urol (2018): 199: 257–265.

448

‘Divorce after 50 grows more common.’ The New York Times (22 September 2013).

449

Gold, E. B. ‘The timing of the age at which natural menopause occurs.’ Obstet Gynecol Clin North Am (2011): 38: 425–440.

450

Hersh, A. L. et al. ‘National use of postmenopausal hormone therapy: annual trends and response to recent evidence.’ JAMA (2004): 291 (1): 47–53.

451

Pal, L. et al. ‘The Women’s Health Initiative: an unforgettable decade.’ Menopause (2012): 19: 597–599.

452

Hersh, A. L. et al. ‘National use of postmenopausal hormone therapy: annual trends and response to recent evidence.’ JAMA (2004): 291 (1): 47–53d.

453

Sarrel, P. M. et al. ‘The mortality toll of oestrogen avoidance: an analysis of excessive deaths among hysterectomized women aged 50 to 59 years.’ Am J Public Health (2013): 103: 1583–1588.

454

Barrett-Connor, E. ‘Sex dif erences in coronary heart disease. Why are women so superior?’ The 1995 Ancel Keys Lecture. Circulation (1997): 95: 252–264.

455

Wellons, M. ‘Early menopause associated with increased risk of heart disease, stroke.’ John Hopkins Medicine (2012).

456

Campos, H. et al. ‘Effect of oestrogen on very low-dose density lipoprotein and low density lipoprotein subclass metabolism in postmenopausal women.’ J Clin Endocrinol Metab (1997): 82 (12): 3955–3963.

457

Mendelsohn, M. E. and Karas, R. H. ‘The protective effects of oestrogen on the cardiovascular system.’ N Engl J Med (1990): 340: 1111–1801.

458

Barrett-Connor, E. ‘Sex dif erences in coronary heart disease. Why are women so superior? The 1995 Ancel keys lecture.’ Circulation (1997): 95: 252–264.

459

Grodstein, F. et al. ‘Postmenopausal estrogen and progestin use and the risk of cardiovascular disease.’ N Engl J Med (1996): 335 (7): 453–461.

460

Blakely, J. A. ‘The Heart and Estrogen/Progestin Replacement Study Revisited. Hormone Replacement Therapy Produced Net Harm, Consistent With the Observational Data.’ JAMA (2000): 160: 2897–2900.

461

‘Hormone Replacement Study A Shock to the Medical System’, The New York Times (10 July 2002). URL: http://www.nytimes.com/2002/07/10/us/hormone-replacement-study-a-shock-to-the-medical-system.html?pagewanted=all.

462

Grodstein, F. et al. ‘Postmenopausal hormone therapy and mortality.’ N Engl J Med (1997): 336: 1769–1776.

463

Rossouw, E. et al. ‘Lessons learned from the Women’s Health Initiative trials of meno-pausal hormone therapy.’ Obstet Gynecol (2003): 121: 172–176. URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC 3547645/.

464

Anderson, G. L. et al. ‘Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women’s Health Initiative randomized controlled trial.’ JAMA (2004): 291: 1701–1712.

465

Rossouw, J. et al. ‘Writing group for the Women’s Health Initiative randomized controlled trial.’ JAMA (2002): 288: 321–333.

466

http://www.icis.com/resources/news/2002/07/17/177264/wyeth-shares-fall-11-to-new-low-on-hormone-drug-fears/.

467

Sarrel, P. M. et al. ‘The mortality toll of oestrogen avoidance: an analysis of excessive deaths among hysterectomized women aged 50 to 59 years.’ Am J Public Health(2013): 103: 1583–1588.

468

Schierbeck, L. L. et al. ‘Effect of hormone replacement therapy on cardiovascular events in recently post-menopausal women: randomised trial’. BMJ (2012): 345: e6409.

469

Sarrel, P. M. et al. ‘The mortality toll of oestrogen avoidance: an analysis of excessive deaths among hysterectomized women aged 50 to 59 years.’ Am J Public Health (2013): 103: 1583–1588.

470

Renoux, C. et al. ‘Transdermal and oral hormone replacement therapy and the risk of stroke: a nested case-control study.’ BMJ (2010): 340: c2519.

471

Rossouw, J. et al. ‘Writing group for the Women’s Health Initiative randomized controlled trial.’ JAMA (2002): 288: 321–333.

472

Schierbeck, L. L. et al. ‘Effect of hormone replacement therapy on cardiovascular events in recently post-menopausal women: randomised trial’. BMJ (2012): 345: e6409.

473

Fournier, A. et al. ‘Risks of endometrial cancer associated with different hormone replace-ment therapies in the E 3N Cohort, 1992–2008.’ Am J Epidemiol Advance Access (2014): 10: 1093.

474

‘The effects of estrogen or estrogen/progestin regimens on heart attack risk factors in post menopausal women. The Postmenopausal oestrogen Progesterone trial (PEPI trial).’ JAMA (1995): 273: 199–208. https://www.ncbi.nlm.nih.gov/pubmed/7807658. Moyer, D. L. et al. ‘Micronized progesterone regulation of the endometrial glandular cycling pool.’ Int J Gynecol Pathol (2001): 20: 374–379.

475

Fournier, A. et al. ‘Unequal risks for breast cancer associated with different hormonal replacement therapies: results from the E 3N cohort study.’ Breast Cancer Res Treat (2008): 107: 103–111.

476

Asi, N. et al. ‘Progesterone vs synthetic progestins and the risk of breast cancer: a systematic review and meta-analysis.’ Syst Rev (2016): 5: 121.

477

‘The effects of estrogen or estrogen/progestin regimens on heart attack risk factors in post menopausal women. The Postmenopausal oestrogen Progesterone trial (PEPI trial).’ JAMA (1995): 273: 199–208. https://www.ncbi.nlm.nih.gov/pubmed/7807658.

478

Diep, C. H. et al. ‘Progesterone action in breast, uterine, and ovarian cancers.’ J Mol Endocrinol (2015): 54: R 31–R 53.

479

‘Cancer incidence for common cancers.’ Cancer Research UK. http://www.cancerresearchuk.org/health-professional/cancer-statistics/incidence/common-cancers-compared#heading-Two.

480

Rinninger, F. et al. ‘Lipoprotein lipase mediates an increase in the selective uptake of high density lipoprotein-associated cholesteryl esters by hepatic cells in culture.’ J Lipid Res (1998): 39 (7): 1335–1348.

481

Price, T. M. et al. ‘Oestrogen regulation of adipose tissue lipoprotein lipase – possible mechanism of body fat distribution.’ Am J Obstet Gynecol (1998): 178: 101–107.

482

Sumino, H. et al. ‘Effects of hormone replacement therapy on weight, abdominal fat distribution and lipid levels in Japanese postmenopausal women.’ Int J Obes (2003): 1044–1051.

483

Jensen, L. B. et al. ‘Hormone replacement therapy dissociates fat mass and bone mass and tends to reduce weight gain in early menopausal women: A randomized prevention study.’ J Bone Miner Res (2003): Vol. 18: 333–342.

484

Sadur, C. N. et al. ‘Insulin stimulation of adipose tissue lipoprotein lipase. Use of the euglycaemic clamp technique.’ J Clin Invest (1982): 69: 1119–1125.

485

Howard, B. V. et al. ‘Insulin resistance and weight gain in post-menopausal women of diverse ethnic groups.’ Int J Obes Relat Metab Disord (2004): 28: 1039–1047.

486

Maybin, J. A. et al. ‘Menstrual physiology: implications for endometrial pathology and beyond.’ Human Reprod (2015): 21: 748–761.

487

Maybin, J. A. et al. ‘Medical management of heavy menstrual bleeding.’ Women’s Health (Long) (2016): 12: 27–34.

488

Smith, S. S. et al. ‘Progesterone alters GABA and glutamate responsiveness: a possible mechanism for its anxiolytic action.’ Brain Res (1987): 400: 353–359.

489

Wang, M. ‘Neurosteroids and GABA-A Receptor Function.’ Front Endocrin (2011): 2: 44.

490

Luine, V. N. et al. ‘Gonadal hormone regulation of MAO and other enzymes in hypo-thalamic areas.’ Neuroendocrinology (1983): 36 (3): 235–241.

491

Cassidenti, D. L. et al. ‘Effects of sex steroids on skin 5 alpha-reductase activity in vitro.’ Obstet Gynecol (1991): 78: 103–107.

492

Payne, A. H. et al. ‘Overview of steroidogenic enzymes in the pathway from cholesterol to active steroid hormones.’ Endocr Rev (2004): 25 (6): 947–970.

493

Skobelov, E. M., Spivey, W. H. et al. ‘The effect of the menstrual cycle on asthma pre sentations in the emergency department.’ Ann Intern Med (1996): 156: 1837–1840.

494

Hanley, S. P. ‘Asthma variation with menstruation.’ Br J Dis Chest (1981): 75: 306–308.

495

Barr, R. G., Wentowski, C. C. et al, ‘Prospective study of postmenopausal hormone use and newly diagnosed asthma and chronic obstructive pulmonary disease.’ Arch Intern Med (2004): 164 (4): 379–386.

496

Foster, P. S., Goldie, R. G., Paterson, J. W. ‘Effect of steroids on β-adrenoceptor-mediated relaxation of pig bronchus.’ Br J Pharmacol (1983): 78: 441–445.

497

Kos-Kudla, B. et al. ‘Effects of hormone replacement therapy on endocrine and spiro-metric parameters in asthmatic postmenopausal women.’ Gynecol Endocrinol(2001): 15: 304–311.

498

Barr, R. G., Wentowski, C. C. et al, ‘Prospective study of postmenopausal hormone use and newly diagnosed asthma and chronic obstructive pulmonary disease.’ Arch Intern Med (2004): 164 (4): 379–386.

499

Miyaura, H. ‘Direct and indirect inhibition of Th1 development by progesterone and glucocorticoids.’ J Immunol (2002): 168: 1087–1094. Hughes, G. C. ‘Progesterone and autoimmune disease.’ Autoimmun Rev (2012): 11: A502–514.

500

Sammaritano, L. R. ‘Menopause in patients with autoimmune diseases.’ Autoimmun Rev (2012): 11: A430–436.

501

Schulze-Koops, H. ‘The balance of Th1/Th2 cytokines in rheumatoid arthritis.’ Best Pract Res Clin Rheumatol (2001): 15: 677–691.

502

Herrera, A. Y. et al. ‘Stress-induced increases in progesterone and cortisol in naturally cycling women.’ Neurobiol Stress (2016): 3: 96–104.

503

http://www.nih.gov/news-events/news-releases/prior-stress-could-worsen-premenstrual-symptoms-nih-study-finds.

504

Roca, C. A. et al. ‘Differential menstrual cycle regulation of hypothalamic-pituitary-adrenal axis in women with premenstrual syndrome and controls.’ J Clin Endocrinol Metab (2003): 88: 3057–3063.

505

Zimmerman, Y. et al. ‘The effect of combined oral contraception on testosterone in healthy women: a systematic review and meta-analysis.’ Hum Reprod Update (2014): 20: 76–105.

506

Persky, H. et al. ‘Plasma testosterone level and sexual behaviour of couples.’ Arch Sex Behav (1978): 7: 157–173.

507

Goldstat, R. et al. ‘Transdermal testosterone therapy improves well-being, mood and sexual function in premenopausal women.’ Menopause (2003): 10: 390–398.

508

Tun, A., Khan, I. A. ‘Acute myocardial infarction with angiographically normal coro-nary arteries.’ Heart Lung (2000): 29: 348–350. Levit, R. D. et al. ‘Cardiovascular disease in young women: a population at risk.’ Cardiol Rev (2011): 19: 60–65.

509

Yang S. et al. ‘Estrogen increases eNOS and NOx release in human coronary artery endothelium.’ J Cardiovasc Pharmacol (2000): 36: 242–247.

510

‘The effects of estrogen or estrogen/progestin regimens on heart attack risk factors in post menopausal women. The Postmenopausal oestrogen Progesterone trial (PEPI trial).’ JAMA (1995): 273: 199–208. URL: https://www.ncbi.nlm.nih.gov/pubmed/7807658.

511

Golden, S. H. et al. ‘Endogenous postmenopausal hormones and carotid atherosclero-sis: a case-control study of the atherosclerosis risk in communities cohort.’ Am J Epidemiol (2002): 155: 437–445.

512

Miller, K. K. et al. ‘Low-dose transdermal testosterone augmentation therapy improves depression severity in women.’ CNS Spectr (2009): 14: 688–694.

513

Goldstat, R. et al. ‘Transdermal testosterone therapy improves well-being, mood and sexual function in premenopausal women.’ Menopause (2003): 10: 390–398.

514

Miller, K. K. et al. ‘Androgen deficiency: association with increased anxiety and depres-sion symptom severity in anorexia nervosa.’ J Clin Psychiatry (2007): 68: 959–965.

515

Hermans, E. J. et al. ‘A single administration of testosterone reduces fear-potentiated startle in humans.’ J Biol Psychiatry (2006): 59: 872–874.

516

Moffat, S. D. et al. ‘Free testosterone and risk for Alzheimer’s disease in older men.’ Neurology (2004): 62: 188–193.

517

Wisniewski, A. B. et al. ‘Evaluation of high dose oestrogen and high dose oestrogen plus methyl-testosterone treatment on cognitive task performance in postmenopausal women.’ Horm Res (2002): 58: 150–155.

518

Naing, S. et al. ‘Hypogonadism in chronic obstructive pulmonary disease.’ Curr Opin Pulm Med (2012): 18: 112–117.

519

Booji, A. et al. ‘Androgens as adjuvant treatment in postmenopausal female patients with rheumatoid arthritis.’ Ann Rheum Dis (1996): 55: 811–815.

520

Naoko, K. et al. ‘Testosterone suppresses anti-DNA antibody production in peripheral blood mononuclear cells from patients with systemic lupus erythematosus.’ Arthritis Rheum (1997): 40: 1703–1711.

521

Pope, Jr, H. G., et al. ‘Effects of supraphysiologic doses of testosterone on mood and aggression in normal men: a randomized controlled trial.’ Arch Gen Psychiatry (2000): 57 (2): 133–140.

522

Santora, L. J. et al. ‘Coronary calcification in bodybuilders using anabolic steroids.’ Prev Cardiol (2006): 9 (4): 198–201.

523

Copley, L. M. et al. ‘Consequences of use of anabolic androgenic steroids.’ Pediatr Clin North Am (2007): 54 (4): 677–690.

524

Sample, B. R. ‘Psychiatric effects and psychoactive substance use in anabolic-andro-genic steroid users.’ Clin J Sport Med (1996): 5 (1): 25–31.

525

Yofkova, I. et al. ‘A decreasing CD 4+/CD 8+ ratio after one month of treatment with Stanozolol in postmenopausal women.’ Steroids (1995): 60: 430–433.

526

Montgomery-Massingberd, H. ‘The Duchess’. The Spectator Archive, (29 September 1978), p. 22.

527

‘Physicians to Stop Injecting Silicone for Cosmetic Treatment of Wrinkles’. Food and Drug Administration press release (1992).

528

Kontis, T. C. et al. ‘The History of Injectable Facial Fillers.’ Facial Plast Surg (2009): 25: 67–72.

529

Greco, R. M. et al. ‘Hyaluronic Acid Stimulates Human Fibroblast Proliferation Within a Collagen Matrix.’ J Cell Physiol (1998): 177: 465–473.

530

Ke, C. et al. ‘Antioxidant Activity of Low Molecular Weight Hyaluronic Acid.’ Food Chem Toxicol (2011): 49: 2670–2675.

531

Chen, W. Y. and Abatangelo, G. ‘Functions of Hyaluronan in Wound Repair.’ Wound Repair Regen (1999): 7 (2): 79–89.

532

Cancer Research UK. URL: http://www.cancerresearchuk.org/health-profes-sional/cancer-statistics/statistics-by-cancer-type/skin-cancer#heading-Zero.

533

Armstrong, B. K. et al. ‘Case-control Study of Sun Exposure and Squamous Cell Carcinoma of the Skin.’ Int J Cancer (1998): 77: 347–353.

534

‘Global, Regional and National Life Expectancy, All-cause Mortality, and Cause-specific Mortality for 249 Causes of Death, 1980–2015: A Systematic Analysis for the Global Burden of Disease Study 2015.’ The Lancet (2016): 388: 1459–1544.

535

Johnston, H. ‘Reduction of Stratospheric Ozone by Nitrogen Oxide Catalysts from Supersonic Transport Exhaust.’ Science (6 August 1971): 173 (3996): 517–522. Molina, M. J., Rowland, F. S. ‘Stratospheric Sink for Chlorofluoromethanes: Chlorine Atom-catalysed Destruction of Ozone.’ Nature (1974): 249: 810–812.

536

‘Ozone and UV: Where Are We Now.’ Skin Cancer Foundation: 27 July 2009: http://www.skincancer.org/prevention/uva-and-uvb/ozone.

537

Godar, D. et al. ‘Cutaneous Malignant Melanoma Incidences Analyzed Worldwide by Sex, Age and Skin Type Over Personal Ultraviolet-B Dose Shows No Role for Sunburn but Implies One for Vitamin D 3.’ Dermato-Endocrinology (2017): Vol. 9, ¹ 1: http://dx.doi.org/10.1080/19381980.2016.1267077.

538

Brash, D. et al. ‘A Role for Sunlight in Skin Cancer: UV–Induced P-53 Mutations in Squamous Cell Carcinoma.’ Proc Natl Acad Sci USA (1991): 88: 10124–10128.

539

Brash, D. E. ‘UV Signature Mutations.’ Photochem Photo-Biol: (2015): 91: 15–26: PMID:25354245: http://dx.doi.org/ 10.1111/php.12377.

540

Cooke, M. S. et al. ‘Oxidative DNA Damage: Mechanisms, Mutation and Disease.’ FASEB J (2003): 17 (10): 1195–1214: PMID:12832285: http://dx.doi.org/10.1096/fj.02–0752rev.

541

Lucas, A. et al. ‘Increased UVA Exposures and Decreased Cutaneous Vitamin D 3 Levels may be Responsible for the Increasing Incidence of Melanoma.’ Medical Hypotheses (2009): 72: 434–443.

542

Nair, R. et al. ‘Vitamin D: the ‘Sunshine’ Vitamin.’ J Pharmacol Pharmacother (2012): 3: 118–26.

543

Von Essen, M. R. et al. ‘Vitamin D Controls T-cell Antigen Receptor Signaling and Activation of Human T-cells.’ Nat Immunol (2010): 11: 344–349: PMID:20208539: http://dx.doi.org/10.1038/ni.1851.

544

Alshishtawy, M. M. ‘Vitamin D Deficiency. A Clandestine Endemic Disease is Veiled No More.’ SQUMJ (2012): 140–152.

545

Lucas, A. et al. ‘Increased UVA Exposures and Decreased Cutaneous Vitamin D 3 Levels may be Responsible for the Increasing Incidence of Melanoma.’ Medical Hypotheses (2009): 72: 434–443.

546

Daya-Grosjean, L. ‘Xeroderma Pigmentosum and Skin Cancer.’ Adv Exp Med Biol (2008): 637: 19–27.

547

Leibeling, D. et al. ‘Nucleotide Excision Repair and Cancer.’ J Mol Histol (2006): 37 (5–7): 225–238.

548

Weber, S. ‘Light-Driven Enzymatic Catalysis of DNA Repair: A Review of Recent Biophysical Studies on Photolyase.’ BBA (2005): Vol. 1707: 1–23.

549

Milani, M. et al. ‘Ei cacy of a Photolyase-Based Device in the Treatment of Cancerization Field in Patients with Actinic Keratosis and Non-Melanoma Skin Cancer.’ G Ital Dermatol Venereol (2013): 148: 693–698.

550

Rudolph, C. M. et al. ‘Squamous Epithelial Carcinoma in Erythema Ab Igne.’ Hautarzt (2000): 51: 260–263.

551

Kligman, L. ‘Intensification of Ultraviolet-Induced Dermal Damage by Infrared Radiation.’ Arch Dermatol Res (1982): 272: 229–238.

552

Schroeder, P. et al. ‘Infrared Radiation-Induced Matrix Metalloproteinase in Human Skin: Implications for Protection.’ J Invest Dermatol (2008): 2491–2497. https://www.ncbi.nlm.nih.gov/pubmed/18449210.

553

Vierkotter, A. et al. ‘MMP-1 and 3-Promoter Variants are Indicative of a Common Susceptibility for Skin and Lung Aging: Results from a Cohort of Elderly Women (SALIA).’ J Invest Dermatol (2015): 135: 1268–1274.

554

Farmer, P. B. et al. ‘Molecular Epidemiology Studies of Environmental Pollutants. Effects of Polycyclic Aromatic Hydrocarbons (PAHs) in Environmental Pollution on Exogenous and Oxidative DNA Damage.’ Mutat Res (2003): 544: 397–402.

555

Huls, A. et al. ‘Trai c-Related Air Pollution Contributes to Development of Facial Lentigines: Further Epidemiological Evidence from Caucasians and Asians.’ J of Invest Dermatol (2016): 136: 1053–1056.

556

Manning, W. J. et al. ‘Ozone and Levels in European and USA Cities are Increasing More Than at Rural Sites, While Peak Values are Decreasing.’ Environ Pollut (2014): 192: 295–299.

557

Valacchi, G. et al. ‘Vitamin C Compound Mixtures Prevent Ozone-Induced Oxidative Damage in Human Keratinocytes as Initial Assessment of Pollution Protection.’ PLoS ONE (2015).

558

Lai, D. et al. ‘Localization of HPV-18 E 2 at Mitochondrial Membranes Induces ROS Release and Modulates Host Cell Metabolism.’ PLoS One (2013): 8 (9): e75625. eCollection 2013: PMID:24086592: http://dx.doi.org/10.1371/journal.pone.0075625.

559

Prabhu, S. R. and Wilson, D. ‘Evidence of Epstein-Barr Virus Associated with Head and Neck Cancers: A Review.’ J Can Dent Assoc (2016): 82: g2: http://www.jcda.ca/g2.

560

Parkin, D. M. ‘The Global Health Burden of Infection-associated Cancers in the Year 2002.’ Int J Cancer (2006): 118 (12): 3030–3044.

561

Dreau, D. et al. ‘Human Papillomavirus in Melanoma Biopsy Specimens and Its Relation to Melanoma Progression.’ Ann Surg (2000): 231 (5): 664–671.

562

Godar, D. et al. ‘Cutaneous Malignant Melanoma Incidences Analyzed Worldwide by Sex, Age and Skin Type Over Personal Ultraviolet-B Dose Shows No Role for Sunburn but Implies One for Vitamin D 3.’ Dermato-Endocrinology (2017): Vol. 9, ¹ 1: http://dx.doi.org/10.1080/19381980.2016.1267077.

563

Wertz, P. W. ‘Lipids and Barrier Function of the Skin.’ Acta Derm Venereol (2000): 208: 7–11.

564

Jackson, M. J. et al. ‘UVR-Induced Oxidative Stress in Human Skin in vivo: Efects of Oral Vitamin C Supplementation.’ Free Radic Biol Med (2002): 33: 1355–1362.

565

Telang, P. S. ‘Vitamin C in Dermatology.’ Indian Dermatol Online (2013): 4: 143–146.

566

Placzek, M. et al. ‘Ultraviolet B-Induced DNA Damage in Human Epidermis is Modified by the Antioxidants Ascorbic Acid and D-alpha-tocopherol.’ J Invest Dermatol (2005): 124: 304–307.

567

Pinnell, S. R. et al. ‘Topical L-ascorbic Acid: Percutaneous Absorption Studies.’ Dermatol Surg (2001): 27: 137–142.

568

Pinnell, S. R. et al. ‘UV Photoprotection by Combination Topical Antioxidants Vitamin C and Vitamin E.’ J Am Acad Dermatol (2003): 48: 866–874.

569

Pinnell, S. R. et al. ‘Protective Effects of a Topical Antioxidant Mixture Containing Vitamin C, Ferulic Acid and Phloretin Against Ultraviolet-Induced Photodamage in Human Skin’. J Cosmet Dermatol (2008): 7: 290–297.

570

Pinnell, S. R. et al. ‘A Topical Antioxidant Solution Containing Vitamins C and E Stabilized by Ferulic Acid Provides Protection for Human Skin Against Damage Caused by Ultraviolet Irradiation.’ J Am Acad Dermatol (2008): 59: 418–425.

571

Kligman, L. ‘Intensification of Ultraviolet-Induced Dermal Damage by Infrared Radiation.’ Arch Dermatol Res (1982): 272: 229–238.

572

Pinnell, S. R. et al. ‘Topical Vitamin C Protects Porcine Skin from Ultraviolet Radiation-Induced Damage.’ Br J Dermatol (1992): 127: 247–253.

573

Pinnell, S. R. et al. ‘Effects of Ascorbic Acid on Proliferation and Collagen Synthesis in Relation to the Donor Age of Human Dermal Fibroblasts.’ J Invest Dermatol (1994): 103: 228–232.

574

Han, B. et al. ‘Transdermal Delivery of Amino Acids and Antioxidants Enhance Collagen Synthesis: In Vivo and In Vitro Studies.’ Connect Tissue Res (2005): 46: 251–257.

575

Thomas, S. et al. ‘Stability, Cutaneous Delivery and Antioxidant Potential of a Lipoic Acid and Alpha-Tocopherol codrug Incorporated in Microemulsions.’ J Pharm Sci (2014): 103: 2530–2538.

576

Beitner, H. ‘Randomized, Placebo-Controlled, Double Blind Study on the Clinical Ei cacy of a Cream Containing 5 % Alpha-Lipoic Acid Related to Photoageing of Facial Skin.’ Br J Dermatol (2003): 149: 841–849.

577

Ahmed, N. et al. ‘The Grape Antioxidant Resveratrol for Skin Disorders: Promise, Prospects and Challenges.’ Arch Biochem Biophys (2011): 508: 164–170.

578

Kligman, A. M. et al. ‘Topical Vitamin A Acid in Acne Vulgaris.’ Arch Dermatol (1969): 469–476.

579

Meyskens, F. L. et al. ‘A Phase-1 Trial of All-Trans-Retinoic Acid Delivered Via a Collagen Sponge and Cervical Cap for Mild or Moderate Intraepithelial Neoplasia.’ J Natl Cancer Inst (1983): 71: 921–925.

580

Kligman, L. H. and Kligman, A. M. ‘Histogenesis and Progression of Ultraviolet Light-Induced Tumours in Hairless Mice.’ J Natl Cancer Inst (1981): 67: 1289–1297.

581

Kligman, L. H. and Kligman, A. M. ‘Topical Retinoic Acid Enhances Repair of Ultraviolet-Damaged Dermal Connective Tissue.’ Connect Tissue Res (1984): 12: 139–150.

582

Kligman, A. M. et al. ‘Topical Tretinoin for Photoaged Skin.’ J Am Acad Dermatol (1986): 15: 836–859.

583

Kligman, A. M. et al. ‘Effects of Topical Tretinoin on Non-Sun-Exposed Protected Skin of the Elderly.’ J Am Acad Dermatol (1993): 29 (1): 25–33.

584

Kligman, A. M. et al. ‘Salicylic Acid Peels for the Treatment of Photoaging.’ Dermatol Surg (1998): 24: 325–328.

585

Hara, T. et al. ‘Platelet-Rich-Plasma Stimulates Human Dermal Fibroblast Proliferation via a Ras-Dependant Extracellular Signal-Regulated Kinase ½ Pathway.’ J Artif Organs (2016): 19: 372–377.

586

Brincat, M. P. ‘Review: Hormone Replacement Therapy and the Skin’. Maturitas (2000): 35: 107–117.

587

Damour, O. et al. ‘Improvement of Skin Quality After Fat Grafting: Clinical Observation and an Animal Study.’ Plast Reconstr Surg (2009): 124: 765–774.

588

Edward, W. et al. ‘The Stromal Vascular Fraction of Autologous Fat Graft Induces Proliferation of Epithelial Progenitor Cells in Healthy and Cancer-Containing Breast Tissue In Vitro.’ Plast Reconstr Surg (2014): 134: 51–52.

589

Jiang, A. et al. ‘Improvement of the Survival of Human Autologous Fat Transplantation by Adipose-Derived Stem-Cells-Assisted Lipotransfer Combined with bFGF.’ Scientific World Journal (2015): 968057.

590

Kuo, T. et al. ‘Collagen Thermal Damage and Collagen Synthesis After Cutaneous Laser Resurfacing.’ Lasers Surg Med (1998): 23: 66–71.

591

Schomaker, K. T. et al. ‘Thermal Damage Produced by High Irradiance Continuous Wave CO2 Laser-Cutting of Tissue.’ Lasers Surg Med (1990): 10: 74–84.

592

Kligman, L. H. ‘Photoaging. Manifestations, Prevention and Treatment.’ Clin Geriatr Med (1989): 51: 235–251.

593

Ogawa, R. et al. ‘Nd: YAG Laser Treatment of Keloids and Hypertrophic Scars.’ Eplasty (2012): 12: e1.

594

Ye, X. et al. ‘Investigation of the 1064 Q-Switched Nd: YAG Laser on Collagen Expression in an Animal Model.’ Photomed Laser Surg (2012): 30: 604–609.

595

Schroeder, P. et al. ‘Infrared Radiation-Induced Matrix Metalloproteinase in Human Skin: Implications for Protection.’ J Invest Dermatol (2008): 2491–2497. https://www.ncbi.nlm.nih.gov/pubmed/18449210.

596

Guzey, M. et al. ‘Increase of Free Oxygen Radicals in Aqueous Humour Induced by Selective Nd: YAG Laser Trabeculoplasty in the Rabbit’. Eur J Opthal (2001): 11: 47–52.

597

Sorg, O. et al. ‘Effect of Intensed Pulsed Light on Lipid Peroxidises and Thymine Dimers.’ Arch Dermatol (2007): 143: 363–366.

598

Elias, P. M. et al. ‘The Aged Epidermal Permeability Barrier: Basis for Functional Abnormalities.’ Clin Geriatr Med (2002): 18: 103–120.

599

Pinnell, S. R. et al. ‘Topical Vitamin C Protects Porcine Skin from Ultraviolet Radiation-Induced Damage.’ Br J Dermatol (1992): 127: 247–253.

600

Elford, E. L. et al. ‘Treatment of Photoaged Skin Using Fractional Nonablative Laser in Combination with Topical Antioxidants.’ URL:.

601

Fazel, S. et al. ‘Long-term Outcomes Associated with Traumatic Brain Injury in Childhood and Adolescence: A Nationwide Swedish Cohort Study of a Wide Range of Medical and Social Outcomes.’ PLOS Medicine (2016): http://dx.doi.org/10.1371/journal.pmed.1002103.

602

Guskiewicz, K. M. et al. ‘Recurrent Concussion and Risk of Depression in Retired Professional Football Players.’ Med Sci Sports Exerc (June 2007): 39 (6): 903–909.

603

Mez, J. et al. ‘Clinicopathological Evaluation of Chronic Traumatic Encephalopathy in Players of American Football.’ JAMA (2017): 318: 360–370.

604

Ñì., íàïðèìåð: www.bbc.com/news/world-us-canada-41356137.

605

Ryan, A. J. ‘Intracranial Injuries Resulting from Boxing.’ Clin Sports Med (January 1998): 17 (1): 155–168.

606

Jordan, B. D. et al. ‘Apolipoprotein E Epsilon4 Associated with Chronic Traumatic Brain Injury in Boxing.’ JAMA (1997): 278: 136–140.

607

Zhou, W. et al. ‘Meta-analysis of APOE 4 and Outcome After Traumatic Brain Injury.’ J Neurotrauma (2008): 25: 279–290.

608

Ñì., íàïðèìåð: ‘Brain Trauma Extends to the Soccer Field’ by John Branch. The New York Times (26 February 2014).

609

McKee, A. C. et al. ‘TDP-43 Proteinopathy and Motor Neurone Disease in Chronic Traumatic Encephalopathy.’ J Neuropathol Exp Neurol (2010): 69 (9): 918–929.

610

Pascual-Leone, A. ‘The Plastic Human Brain Cortex.’ Ann Rev Neurosci (2005): 28: 377–401.

611

Merzenich, M. M. et al. ‘Somatosensory Cortical Map Changes Following Digit Amputation in Adult Monkeys.’ J Comp Neurol (1984): 224 (4): 591–605.

612

Maguire, E. A. et al. ‘London Taxi Drivers and Bus Drivers: A Structural MRI and Neuropsychological Analysis.’ Hippocampus (2006): 16: 1091–1101.

613

Draganski, B. et al. ‘Temporal and Spatial Dynamics of Brain Structure Changes during Extensive Learning.’ J Neurosci (7 June 2006): 26 (23): 6314–6317.

614

Gaser, C. et al. ‘Brain Structures Dif er Between Musicians and Non-musicians.’ J Neurosci (2003): 23: 9240–9245.

615

Mechelli, A. et al. ‘Neurolinguistics: Structural Plasticity in the Bilingual Brain.’ Nature (2004): 431: 757.

616

Draganski, B. et al. ‘Neuroplasticity: Changes in Grey Matter Induced by Training.’ Nature (2004): 427: 311–312.

617

Boyke, J. et al. ‘Training-induced Brain Structure Changes in the Elderly.’ J Neurosci (2008): 28: 7031–7035.

618

Hara, Y. ‘Brain Plasticity and Rehabilitation in Stroke Victims.’ J Nippon Med Sch (2015): 82: 4–13.

619

Boldrini, M. et al. ‘Human hippocampal neurogenesis persists throughout aging.’ Cell Stem Cell (2018): 22: 589–599.

620

Weir, K. ‘The Lasting Impact of Neglect.’ American Psychological Association (2014): 45 (6): 36.

621

‘An 80-Year-Old Model Reshapes China’s Views on Aging’. The New York Times (3 November 2016).

622

Bhullar, N. et al. ‘Dispositional Gratitude Mediates the Relationship Between a Past-Positive Temporal Frame and Well-being.’ Science Direct (2015): 76: 52–55.

623

Mang, C. S. ‘Promoting Neuroplasticity for Motor Rehabilitation After Stroke: Considering the Effects of Aerobic Exercise and Genetic Variation on Brain-Derived Neurotrophic Factor.’ Phys Ther (2013): 93: 1707–1716.

624

Larson, E. B. et al. ‘Exercise is Associated with Reduced Risk for Incident Dementia Among Persons 65 Years of Age or Older.’ Ann Intern Med (2006): 144: 73–81.

625

Seinfeld, S. et al. ‘Effects of Music Learning and Piano Practice on Cognitive Function, Mood and Quality of Life in Older Adults.’ Front Psychol (2013): 4: 810.

626

Sherrington, C. et al. ‘Effective Exercise for the Prevention of Falls: A Systematic Review and Meta-analysis.’ J Am Geriatr Soc (2008): 56: 2234–2243.

627

Alladi, S. et al. ‘Bilingualism Delays Age at Onset of Dementia, Independent of Education and Immigration Status.’ Neurology (2013).

628

Kattenstroth, J.-C. et al. ‘Superior Sensory, Motor and Cognitive Performance in Elderly Individuals with Multi-year Dancing Activities.’ Front Aging Neurosci (21 July 2010).

629

Chollet, F. et al. ‘Fluoxetine for Motor Recovery After Acute Ischaemic Stroke (FLAME): A Randomised Placebo-controlled Trial.’ Lancet Neurol (2011): 10: 123–130.

630

Hen, R. et al. ‘Chronic Fluoxetine Stimulates Maturation and Synaptic Plasticity of Adult-born Hippocampal Granule Cells.’ J Neurosci (2008): 1374–1384.

631

Mao, Q. Q. et al. ‘Long-term Treatment with Peony-glycosides Reverses Chronic Unpredictable Mild Stress-induced Depressive-like Behaviour via Increasing Expression of Neurotrophins in Rat Brain.’ Behav Brain Res (2010): 210: 171–177.

632

‘Virtual Reality for Stroke Rehabilitation.’ Cochrane (February 2015):.

633

Swaab, D. et al. ‘Elevated Cortisol in Rats Induces Neuronal Damage.’ Ageing Res Rev (2005): 4 (2): 141–194.

634

Chetty, S. et al. ‘Stress and Glucocorticoids Promote Oligodendrogenesis in the Adult Hippocampus.’ Mol Psychiatry (2014): 19: 1275–1283.

635

Lupien, S. et al. ‘The Douglas Hospital Longitudinal Study of Normal and Pathological Aging.’ J Psychiatry Neurosci (2005): 30: 328–334.

636

Steptoe, A. et al. ‘Depression and Elevated Cortisol.’ Am J Epidemiol (2008): 167 (1): 96–102.

637

Flint, M. S. et al. ‘Induction of DNA Damage, Alteration of DNA Repair and Transcriptional Activation by Stress Hormones.’ Psychoneuroendocrinology (2007): 32 (5): 470–479.

638

Thaker, P. H. et al. ‘Chronic Stress Promotes Tumor Growth and Angiogenesis in a Mouse Model of Ovarian Carcinoma.’ Nat Med (2006): 12: 939–944.

639

Goldstein DS. ‘Review: Catecholamines and Stress.’ Endocr Regul (June 2003): 37 (2): 69–80.

640

Lu, T. et al. ‘Gene Regulation and DNA Damage in the Ageing Human Brain.’ Nature (24 June 2004): 429 (6994): 883–891.

641

Russ, T. C. ‘Association Between Psychological Distress and Mortality: Individual Participant Pooled Analysis of 10 Prospective Cohort Studies.’ BMJ (2012): 345.

642

Gu, X. et al. ‘Anterior Insula Cortex and Emotional Awareness.’ J Comp Neurol (2013): 521: 3371–388.

643

Haase, L. et al. ‘Mindfulness-based Training Attenuates Insula Response to an Aversive Interoceptive Challenge.’ Soc Cogn Affect Neurosci (2016): 11: 182–190.

644

Lazer, S. W. et al. ‘Meditation Experience is Associated with Increased Cortical Thickness.’ Neuroreport (2005): 16: 1893–1897.

645

Ñì., íàïðèìåð: http://news.harvard.edu/gazette/story/2011/01/eight-weeks-to-a-better-brain/.

646

Epel, E. et al. ‘Can Meditation Slow Rate of Cell Ageing? Cognitive Stress, Mindfulness and Telomeres.’ Ann N Y Acad Sci (2009): 1172.

647

Babiloni, C. et al. ‘Resting State Cortical Rhythms in Athletes. A High-resolution EEG Study.’ Brain Res Bull (2010): 81: 149–156.

648

Babiloni, C. et al. ‘Intra-hemispheric Functional Coupling of Alpha Rhythms is Related to a Golfer’s Performance: A Coherence EEG Study.’ Int J Psychophysiol (2011): 82: 260–268.

649

Moore, N. ‘A Review of EEG Biofeedback Treatment of Anxiety Disorders.’ Clin EEG Neurosci (2000): 31: 1–6.

650

Lustenberger, C. et al. ‘Functional Role of Frontal Alpha Oscillations in Creativity.’ Cortex (2015): 67: 74–82.

651

Warmsley, E. et al. ‘Memory, Sleep and Dreaming: Experiencing Consolidation.’ Sleep Med Clin (2011): 6: 97–108.

652

Ñì., íàïðèìåð: ‘David Blaine Braves Brain Damage to Challenge World Record for Staying Awake’ by Richard Simpson. Mail Online (5 December 2007).

653

Schenkein, J. et al. ‘Self-management of Fatal Familial Insomnia. Part 1: What is FFI?’ MedGenMed (2006): 8: 65.

654

Ohayon, M. et al. ‘National Sleep Foundation’s Sleep Quality Recommendations: First Report.’ Sleep Health (2017): Vol 3, Issue 1: 6–19.

655

Moore, D. ‘Eyes Wide Open: Americans, Sleep and Stress’ (12 February 2002). http://www.gallup.com/poll/5314/eyes-wide-open-americans-sleep-stress.aspx.

656

Williamson, A. M. et al. ‘Moderate Sleep Deprivation Produces Impairments in Cognitive and Motor-performance Equivalent to Legally Prescribed Levels of Alcohol Intoxication.’ Occup Environ Med (2000): 57: 649–655.

657

Nagai, M. et al. ‘Sleep Duration as a Risk Factor for Cardiovascular Disease – A Review of the Recent Literature.’ Curr Cardiol Review (2010): 6: 54–61.

658

Ñì., íàïðèìåð: https://www.worldhealth.net/news/sleep-apnea-wreaks-havoc-your-metabolism/.

659

Verkasalo, P. K. et al ‘Sleep Duration and Breast Cancer: A Prospective Cohort Study’. Cancer Res (2005): 65: 9595–9600. Mullington, J. et al. ‘Sleep Loss and Infl ammation.’ Best Pract Res Clin Endocrinol Metab (2010): 24 (5): 775–784.

660

Scullin, M. et al. ‘Sleep Cognition and Normal Aging: Integrating a Half-century of Multidisciplinary Research.’ Sage Journals (2015). http://journals.sagepub.com/doi/abs/10.1177/1745691614556680.

661

Xie, L. et al. ‘Sleep Drives Metabolite Clearance from the Adult Brain.’ Science (2013): 342: 373–377.

662

Boyce, R. et al. ‘Causal Evidence for the Role of REM Sleep Theta Rhythm in Contextual Memory Consolidation.’ Science (2016): 352: 812–816.

663

Eugene, A. R. ‘The Neuroprotective Aspects of Sleep.’ MEDtube Sci (2015): 3: 35–40.

664

Chrousos, G. P. et al. ‘Sleep Deprivation Effects on the Activity of the Hypothalamic-pituitary-adrenal and Growth Axes: Potential Clinical Implications.’ Clin Endocrinol (1999): 51: 205–215.

665

Wittert, G. ‘The Relations Between Sleep Disorders and Testosterone in Men.’ Asian J Androl (2014): 16: 262–265.

666

Davidson, J. R. et al. ‘Growth Hormone and Cortisol Secretion in Relation to Sleep and Wakefulness.’ J Psychiatry Neurosci (1991): 16: 96–102.

667

Kloss, J. D. et al. ‘Sleep, Sleep Disturbance and Fertility in Women.’ Sleep Med Rev (2015): 22: 78–87.

668

ÃÀÌÊ – ýòî àááðåâèàòóðà íàçâàíèÿ íåéðîìåäèàòîðà ãàììà-àìèíîìàñëÿíîé êèñëîòû; åãî ôóíêöèÿ çàêëþ÷àåòñÿ â ñíèæåíèè àêòèâíîñòè â òåõ íåéðîíàõ, ê êîòîðûì îí ïðèñîåäèíÿåòñÿ, äðóãèìè ñëîâàìè – â ÃÀÌÊ-ðåöåïòîðàõ. Êîãäà ýòî ïðîèñõîäèò, âû ðàññëàáëÿåòåñü. – Ïðèì. àâòîðà.

669

Longo, L. P. and Johnson, B. ‘Addiction Part 1: Benzodiazepines – Side effects, Abuse Risk and Alternatives.’ Am Fam Physician (1 April 2000): https://pdfs.semanticscholar.org/725c/bab0f1060a771d1d5c5d6cf2594e1d8c91be.pdf.

670

Parker, G. B. et al. ‘Determinants of Treatment-resistant Depression: The Salience of Benzodiazepines.’ J Nerve Ment Dis (2015): 203: 659–663.

671

Pagel, J. F. et al. ‘Medications for the Treatment of Sleep Disorders: An Overview.’ Prim Care Companion J Clin Psychiatry (2001): 3: 118–125.

672

Malhotra, S. et al. ‘The Therapeutic Potential of Melatonin: A Review of the Science.’ MedGenMed (2004): 6: 46.

673

Patorno, E. et al. ‘Benzodiazepines and risk of all cause mortality in adults: cohort study.’ BMJ (2017): 358: j2941.

674

CBT-I is strongly recommended by the American College of Physicians as the first-line treatment for people suf ering from chronic insomnia – not sleeping tablets.

675

Eriksson, E. et al. ‘Consistent Superiority of Selective Serotonin Re-uptake Inhibitors Over Placebo in Reducing Depressed Mood in Patients with Major Depression.’ Mol Psychiatry (2016): 21: 523–530.

676

Owens, M. J. et al. ‘Role of Serotonin in Pathophysiology of Depression: Focus on the Serotonin Transporter.’ Clin Chem (1994): 40: 288–295.

677

Smith, K. A. et al. ‘Relapse of Depression After Rapid Depletion of Tryptophan.’ The Lancet (1997): 349: 915–919.

678

Swaab, D. et al. ‘Elevated Cortisol in Rats Induces Neuronal Damage.’ Ageing Res Rev (2005): 4 (2): 141–194.

679

Hen, R. et al. ‘Chronic Fluoxetine Stimulates Maturation and Synaptic Plasticity of Adult-born Hippocampal Granule Cells.’ J Neurosci (2008): 1374–1384.

680

Mao, Q. Q. et al. ‘Long-term Treatment with Peony-glycosides Reverses Chronic Unpredictable Mild Stress-induced Depressive-like Behaviour via Increasing Expression of Neurotrophins in Rat Brain.’ Behav Brain Res (2010): 210: 171–177.

681

Benicky, J. et al. ‘Blockade of Brain Angiotensin II Receptors Ameliorates Stress, Anxiety, Brain Infl ammation and Ischaemia: Therapeutic Implications.’ Psychoneuroendocrinology (2011): 36: 1–18.

682

Dantzer, R. et al. ‘Infl ammation-associated Depression: From Serotonin to Kynurenine.’ Psychoneuroendocrinology 36: 426–436.

683

Bremmer, M. A. et al. ‘Infl ammatory Markers in Late-life Depression: Results from a Population-based Study.’ J Af ect Disord (2008): 106: 249–255.

684

Lieberman, D. E. ‘Evolution’s Sweet Tooth.’ The New York Times (5 June 2012).

685

Greer, S. et al. ‘The Impact of Sleep Deprivation on Food Desire in the Human Brain.’ Nat Commun (2013): 4: 2259.

686

Rada, P. ‘Daily Bingeing on Sugar Repeatedly Releases Dopamine in the Accumbens Shell.’ Neuroscience (2005): 737–744.

687

Tanda, G. et al. ‘Cannabinoid and Heroin Activation of Mesolimbic Dopamine Transmission by a Common μ Opioid Receptor Mechanism.’ Science (1997): 276: 2048–2850.

688

Volkow, N. D. et al. ‘Imaging Dopamine’s Role in Drug Abuse and Addiction.’ Neuropharmacology (2009): 56: 3–8.

689

‘DSM IV Substance Dependence Criteria.’ American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (4th ed.) American Psychiatric Association (2000).

690

Alexander, B. K. et al. ‘The Effect of Housing and Gender on Morphine Self-administration in Rats.’ Psychopharmacology (1978): 58: 175–179.

691

Robins, L. ‘Vietnam Veterans’ Rapid Recovery From Heroin Addiction: A Fluke or Normal Expectation?’ Addiction (1993): 88: 1041–1054.

692

Owens, M. J. et al. ‘Role of Serotonin in Pathophysiology of Depression: Focus on the Serotonin Transporter.’ Clin Chem (1994): 40: 288–295.

693

Walker, M. et al. ‘The Impact of Sleep Deprivation on Food Desire in the Human Brain.’ Nat Commun (2013): 2259.

694

Sinha, R. ‘Chronic Stress, Drug Use and Vulnerability to Addiction.’ Ann NY Acad Sci (2008): 1141: 105–130.

695

Dinan, T. G. ‘Glucocorticoids and the Genesis of Depressive Illness. A Psychobiological Model.’ Br J Psychiatry (1994): 164: 365–371.

696

Smith, K. A. et al. ‘Relapse of Depression After Rapid Depletion of Tryptophan.’ The Lancet (1997): 349: 915–919.

697

Ïî ìàòåðèàëàì ñàéòà Alzheimer’s Association alz.org.

698

Hurd, M. et al. ‘Monetary Costs of Dementia in the United States.’ N Engl J Med (2013): 368: 1326–1334.

699

Eli Lilly statement: http://lilly.mediaroom.com/index.php?s=9042&item=137604.

700

Powell, A. ‘Plotting the Demise of Alzheimer’s.’ Harvard Gazette(April 2017). URL: https://news.harvard.edu/gazette/story/2017/04/harvard-researchers-plot-early-attack-against-alzheiers/.

701

Ibid.

702

Hasselmo, M. E. ‘The Role of Acetylcholine in Learning and Memory.’ Curr Opin Neurobiol (2006): 16 (6): 710–715.

703

Coyle, J. T. et al. ‘Alzheimer’s Disease: A Disorder of Cortical Cholinergic Innervation.’ Science (1983): 219: 1184–1190.

704

Nieoullon, A. ‘Acetylcholinesterase Inhibitors in Alzheimer’s Disease: Further Comments on Their Mechanisms of Action and Therapeutic Consequences.’ Psychol Neuropsych Vieil (2010): 8: 123–131.

705

Moslemnezhad, A. et al. ‘Altered Plasma Marker of Oxidative DNA Damage and Total Antioxidant Capacity in Patients with Alzheimer’s Disease.’ Caspian J Intern Med (2016): 7: 88–92.

706

Cacabelos, R. et al. ‘The Glutamatergic System and Neurodegeneration in Dementia: Preventive Strategies in Alzheimer’s Disease.’ Int J Geriatr Psychiatry (1999): 14: 3–47.

707

Parsons, C. G. et al. ‘Glutamate in CNS Disorders as a Target for Drug Development: An Update.’ Drugs New Perspect. I (November 1998): 523–569.

708

Goedert, M. et al. ‘Tau Proteins and Neurofibrillary Degeneration.’ Brain Pathol (1991): 1: 279–286.

709

Deane, R. et al. ‘The Role of the Blood-brain Barrier in the Pathogenesis of Alzheimer’s Disease.’ Curr Alzheimer Res (2007): 4: 191–197.

710

Hardy, J. et al. ‘Amyloid Deposition as the Central Event in the Aetiology of Alzheimer’s Disease.’ Trends Pharmacol Sci (1991): 12: 383–388.

711

Xie, L. et al. ‘Sleep Drives Metabolite Clearance from the Adult Brain.’ Science (2013): 342: 373–377.

712

Spira, A. et al. ‘Impact of Sleep on Cognitive Decline and Dementia.’ Curr Opin Psychiatry (2014): 27: 478–483.

713

Mergenthaler, P. et al. ‘Sugar for the Brain: The Role of Glucose in Physiological and Pathological Brain Function.’ Trends Neurosci (2013): 36: 587–597.

714

Berti, V. et al. ‘PET/CT in Diagnosis of Dementia.’ Ann NY Acad Sci(2011): 1228: 81–92.

715

Reiman, E. M. et al. ‘Functional Brain Abnormalities in Young Adults at Genetic Risk for Late-onset Alzheimer’s Dementia.’ Proc Natl Acad Sci USA (2004): 101: 284–289.

716

Moreira, P. I. ‘High-sugar Diets, Type-2 Diabetes and Alzheimer’s Disease.’ Curr Opin Clin Nutrit Metab Care (2013): 16: 440–445.

717

Kiyohara, Y. et al. ‘Glucose Tolerance Status and Risk of Dementia in the Community: The Hisayama Study.’ Neurology (2011): 77 (12): 1126.

718

Feldman, E. et al. ‘Insulin-resistance is a Key Link for the Increased Risk of Cognitive Impairment in the Metabolic Syndrome.’ Exp Mol Med (2015): 47: e149.

719

Claxton, A. et al. ‘Long-acting Intranasal Insulin Detemir Improves Cognition for Adults with Mild Cognitive Impairment or Early-stage Alzheimer’s Disease Dementia.’ J Alzheimers Dis (2015): 44: 897–906.

720

Cao, D. et al. ‘Intake of Sucrose-sweetened Water Induces Insulin Resistance and Exacerbates Memory Deficits and Amyloidosis in a Transgenic Mouse Model of Alzheimer’s Disease.’ J Biol Chem (2007): 282: 36275–36282.

721

Pivovarova, O. et al. ‘Insulin-degrading Enzyme: New Therapeutic Target for Diabetes and Alzheimer’s Disease.’ Ann Med (2016): 48: 614–624.

722

Ward, A. et al. ‘Prevalence of Apolipoprotein E 4 Genotype and Homozygotes (APOE e4/4) among Patients Diagnosed with Alzheimer’s Disease: A Systematic Review and Meta-analysis.’ Neuroepidemiology (2012): 38 (1): 1–17.

723

Chia-Chen, L. et al. ‘Apolipoprotein-E and Alzheimer’s Disease: Risk, Mechanisms and Therapy.’ Nat Rev Neurol (2013): 9: 106–118.

724

Dietschy, J. M. ‘Central Nervous System: Cholesterol Turnover, Brain Development and Neurodegeneration.’ Biol Chem (2009): 390: 287–293.

725

West, R. et al. ‘Better Memory-functioning Associated with Higher Total and Low-density Lipoprotein Cholesterol Levels in Very Elderly Subjects without the apolipoprotein E 4 Allele.’ Am J Geriatr Psychiatry (2008): 16: 781–785.

726

Lane-Donovan, C. et al. ‘High-Fat Diet Changes Hippocampal Apolipoprotein E (ApoE) in a Genotype- and Carbohydrate-Dependent Manner in Mice.’ PLoS One (2016): 11 (2): e0148099.

727

Lanctot, C. et al. ‘Correlates of Response to Acetylcholinesterase Inhibitor Therapy in Alzheimer’s Disease.’ J Psychiatry Neurosci (2003): 28: 13–26.

728

Head, D. et al. ‘Exercise Engagement as a Moderator of the Effects of APOE Genotype on Amyloid Deposition.’ Arch Neurol (2012): 69 (5): 636–643.

729

White, H. et al. ‘Clinical Review: Ketones and Brain Injury.’ Crit Care (2011): 15: 219.

730

Cunnane, S. et al. ‘Can Ketones Help Rescue Brain Fuel Supply in Later Life? Implications for Cognitive Health during Aging and the Treatment of Alzheimer’s Disease.’ Front Mol Neurosci (2016): 9: 53.

731

Henderson, S. T. et al. ‘Study of the Ketogenic Agent AC-1202 in Mild to Moderate Alzheimer’s Disease: A Randomized, Double-blind, Placebo-controlled, Multicenter trial.’ Nutr Metab (Lond) (2009): 6: 31.

732

White, H. et al. ‘Clinical Review: Ketones and Brain Injury.’ Crit Care (2011): 15: 219.

733

Krikorian, R. et al. ‘Dietary Ketosis Enhances Memory in Mild Cognitive Impairment.’ Neurobiol Aging (2012): 33: 19–25.

734

Maalouf, M. et al. ‘The Neuroprotective Properties of Calorie Restriction, the Ketogenic Diet and Ketone Bodies.’ Brain Res (2009): 59: 293–315.

735

Li, L. et al. ‘Chronic Intermittent Fasting Improves Cognitive Functions and Brain Structures in Mice.’ Plos One (2013): 8: e66069.

736

Saucedo Marquez, C. M. et al. ‘High-intensity Interval Training Evokes Larger Serum BDNF Levels Compared with Intense Continuous Exercise.’ J Appl Physiol (2015): 119: 1363–1373.

737

Heyn, P. et al. ‘The Effects of Exercise Training on Elderly Persons with Cognitive Impairment and Dementia: A Meta-analysis.’ Arch Phys Med Rehabil (2004): 85 (10):1694–1704.

738

Sharipour, R. B. et al. ‘N-Acetylcysteine (NAC) in Neurological Conditions: Mechanisms of Action and Therapeutic Opportunities.’ Brain Behav (2014): 4: 108–122.

739

Littlejohns, T. J. et al. ‘Vitamin D and the Risk of Dementia and Alzheimer’s Disease.’ Neurology (2014): 83: 920–928.

740

Sabeti, J. et al. ‘Steroid Pregnenolone Sulfate Enhances NMDA-receptor-independent Long-term Potentiation at Hippocampal CA1 Synapses: Role for L-type Calcium Channels and Sigma-Receptors.’ Hippocampus (2007): 17 (5): 349–369.

741

The Lancet Commission on pollution and health (19 October 2017).

742

Sparano, J. A. et al. ‘Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer.’ N Engl J Med (2018). URL: https://www.nejm.org/doi/full/10.1056/NEJMoa180471.

743

Kilpeläinen, T. O. et al. ‘Physical activity attenuates the influence of FTO variants on obesity risk: A meta-analysis of 218,166 adults and 19,268 children.’ PLoS Medicine (2011).

744

Reardon, S. ‘Modified viruses deliver death to antibiotic-resistant bacteria.’ Nature (2017): 546.

745

Liao, H. K. et al. ‘In Vivo Target Gene Activation via CRISPR/Cas9-Mediated Trans-epigenetic Modulation.’ Cell (2017): 171: 1495–1507. Sanz, D. J. et al. ‘Cas9/gRNA targeted excision of cystic fibrosis-causing deep-intronic splicing mutations restores normal splicing of CFTR mRNA.’ PLoS One (2017): 12.

746

Powell, A. ‘Recalling a lab-led rescue.’ Harvard Gazette (2013).

747

Voltarelli, J. C. et al. ‘Autologous Nonmyeloablative Hematopoietic Stem Cell Transplantation in Newly Diagnosed Type 1 Diabetes Mellitus.’ JAMA (2007): 297: 1568–1576.

748

Lee, S. S. et al. ‘Gel scaf olds of BMP-2-binding peptide amphiphile nanofibers for spinal arthrodesis.’ Adv Healthcare Mat (2015): 4: 131–141.

749

Zhang, G. et al. ‘A delivery system targeting bone formation surfaces to facilitate RNAi-based anabolic therapy.’ Nat Med (2012): 18: 307–314.

750

Webber, M. J. et al. ‘Development of bioactive peptide amphiphiles for therapeutic cell delivery.’ Acta Biomater (2010): 6: 3–9.

751

‘Heart-muscle patches made with human cells improve heart attack recovery.’ ScienceDaily (2018).

752

Filareto, A. et al. ‘An ex vivo gene therapy approach to treat muscular dystrophy using inducible pluripotent stem cells.’ Nat Commun (2013): 4: 1549.

753

Ma, K. et al. ‘Synergetic Targeted Delivery of Sleeping-Beauty Transposon System to Mesenchymal Stem Cells Using LPD Nanoparticles Modified with a Phage-Displayed Targeting Peptide.’ Adv Funct Mater (2013): 23: 1172–1181.

754

Zhang, Y. et al. ‘Hypothalamic stem cells control ageing speed partly through exosomal miRNAs.’ Nature (2017): 548: 52–57.

755

Wyss-Coray, T. et al. ‘Young blood reverses age-related impairments in cognitive function and synaptic plasticity in mice.’ Nat Med (2014): 20: 659–663.

756

Wyss-Coray, T. et al. ‘Human umbilical cord plasma proteins revitalize hippocampal function in aged mice.’ Nature (2017): 544: 488–492.

757

Kawaguch, J. ‘People/Words to Live By: Author/physician Shigeaki Hinohara.’ The Japan Times (29 January 2009).

Âåðíóòüñÿ ê ïðîñìîòðó êíèãè Âåðíóòüñÿ ê ïðîñìîòðó êíèãè